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Introduction 
 
Odontogenic tumours constitute a heterogeneous group of lesions. Their 
formation sometimes simulates the inductive interaction that normally oc-
curs when teeth are formed. Others are composed of soft tissues only 
mimicking ameloblasts, odontoblasts or odontogenic mesenchymal tissue 
in various compositions.10 Odontogenic tumours are unique in that they 
only occur in the maxillofacial region. They are usually benign but may 
attain considerable size giving rise to visible disfigurement of the face 
(Fig. 1). Malignant odontogenic tumours are rare but may occur.14,23,51,61 
In the latter case they may be found 
elsewhere in the body as a result of 
metastasis.76 There are many ex-
cellent review studies on odontogenic 
tumours describing epidemiologic 
data, the clinical presentation, histol-
ogy and mode of treatment for the 
various tumours.1,11,21,37,39,44,47,62,74  
Most of these studies, however, are 
based on research carried out in 
Western countries or Asia. The 
situation in Africa is quite different, 
which is mainly due to the fact that 
patients tend to present late with 
relatively large tumours that require drastic surgery, leaving the patient 
with a large defect, that often leads to severe invalidation.45,58 
Fig. 1: Patiënt with a large odonto-
genic tumour. 
In Africa and most likely also in other less developed countries in Asia 
and probably elsewhere, socio-economic factors determine for a large 
part the level of health care. Since these countries usually have a fairly 
low gross domestic product (GDP) per capita, the level of health care is 
relatively low as well. One has to realise that most of these countries also 
have to deal with an overwhelming number of patients suffering from 
malaria, malnutrition and human immunodeficiency virus (HIV) or other 
infectious diseases.32,42,67,73 This fact alone is responsible for a tremen-
dous claim on the health care budget and implies that patients with 
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odontogenic tumours do not receive the attention they should deserve, 
whereas the means for time consuming and expensive methods of recon-
struction, for a relatively small group of patients, are not readily available. 
In addition to the economic constraints there are factors related to the 
way of life of most people in Africa. Patients have very low income and 
are usually not insured, which causes them to postpone treatment as long 
as possible, whereas absence of work for those living in urban areas also 
implies absence of income. The majority of them live in tribal communities 
in rural areas where traditional medicine is still widely practiced.43 As a 
result of all above mentioned factors, patients tend to walk around with 
their tumour until it reaches an enormous size or until it precludes normal 
jaw function.45,58 Patients, therefore, present with lesions that are not of-
ten seen in the Western, developed world. Surgical treatment in most of 
these cases implies resection of a large part of the jaw without adequate 
reconstruction, rendering these patients facial cripples. 
 
Factors related to the Tanzanian situation 
 
Tanzania is a big country with an area of approximately 945,000 square 
kilometers and a population of 34 million people, most of whom are living 
in rural areas.8,48 The health system in Tanzania is organised in such a 
way that a patient with an odontogenic tumour is supposed to be seen at 
a primary health care centre (dispensaries and health centres) where, 
after the clinical diagnosis is made, he or she is referred to the district 
hospital. Unfortunately, Tanzania like many other African countries has an 
acute shortage of dental personnel. The majority of district hospitals have 
low cadre dental personnel (dental therapist). This cadre is trained to offer 
basic dental treatment and when appropriate refer to a dental surgeon 
who, in most cases, is only available at a regional hospital. After years of 
service this cadre can undergo an upgrading course and become Assis-
tant Dental Officer (ADO). In the districts where there is no dental per-
sonnel medical practitioners see such patients. Although the government 
have made efforts to take health care nearer to the people,34 it is also true 
that in many districts, either because of distance or due to economic rea-
 14
sons, it is not easy for the ordinary person to travel to the district hospital 
for the basic dental care required. 
The majority of Tanzanians, however, do not undergo a regular medical 
or dental check up. People go to see medical or dental personnel only 
when they have severe problems that interfere with their routine life. 
Considering the complexities involved in reaching an accurate diagnosis, 
which almost always requires sophisticated laboratory investigations, 
misdiagnosis at the level of the district hospital is very well possible. A 
histological investigation, which is the single most accurate means of pro-
viding a definite diagnosis, can only be obtained at two referral centres in 
the whole country. A misdiagnosis often leads to wrong treatment, re-
sulting in unnecessary cost and delay in referring the patient to the ap-
propriate centres. For example, some patients with odontogenic tumours, 
having been wrongly diagnosed as cases of infection, were treated with 
antibiotics for several months before a decision to refer them was 
reached. In other instances a conservative surgical approach was at-
tempted for a relatively aggressive tumour, in which case recurrence of 
the tumour was inevitable. Most recurrent tumours pose extra challenges, 
in that it is more difficult to eradicate the tumour and to reconstruct the re-
sultant defect.12,15 
Controversy also exists with regard to interpretation of epidemiologic 
data. For example, the only published study on odontogenic tumours in 
Tanzania categorised ameloblastoma under “cancers”.60 Other African 
studies on odontogenic tumours do not clearly differentiate between 
prevalence and incidence rate, with the majority of them calculating the 
relative frequencies only, making it difficult to understand the magnitude 
of the problems associated with the occurrence of odontogenic tu-
mours.36,47 
Any mode of treatment, that requires close follow-up of the patient to 
monitor recurrences at an early stage, can hardly be effective in the Tan-
zanian environment where the majority of the patients disappear from 
follow-up immediately after surgery. Should any recurrences occur the 
patients would again report late with huge tumours making management 
even more complicated! 
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Treatment of odontogenic tumours 
 
A review of the literature shows a diversity of opinions on how to effec-
tively manage the most common odontogenic tumours, however, the ba-
sic factor on planning their management is the clinical and pathological 
behaviour.2,3,4,9,18,19,22,35,40,41,46,54,72 The less aggressive benign odonto-
genic tumours, the majority of which originate from the ectomesenchyme 
or from a mixed ectodermal and ectomesenchymal origin, are capsulated 
and are not locally invasive.27 This makes it possible to treat them con-
servatively. This group includes odontoma, ameloblastic fibroma, adeno-
matoid odontogenic tumour (AOT) and the calcifying odontogenic cyst. 
Enucleation by removal of the tumour entirely with its capsule or enu-
cleation and curettage are the most often employed approaches for this 
group of lesions.9,27,56,68 This approach has the advantage that no conti-
nuity resection has to be carried out in most cases and therefore, the re-
sulting defect is much less disfiguring as compared to the one left after 
the treatment of the aggressive type of tumours. Nonetheless, even the 
non-aggressive odontogenic tumours, when diagnosed at late stages 
when they have involved and destroyed big portions of the jaws, will re-
quire complicated management.45 Although treatment may imply enu-
cleation of the tumour only, loss of other structures like teeth and nerve 
and gross weakening of the remaining portion of the jawbone, which pre-
disposes to fractures and loss of function, may further complicate the 
whole situation. 
The benign but aggressive odontogenic tumours are essentially those of 
ectodermal origin, in which group are found ameloblastomas, calcifying 
epithelial odontogenic tumour (CEOT), squamous odontogenic tumour 
and the malignant clear cell odontogenic carcinoma.5,6,27,38,59,69,75 Odonto-
genic myxoma, though belonging to the group of tumours of mesenchy-
mal origin, lacks a capsule and therefore, mostly behaves like the other 
benign, but locally aggressive tumours. The management of such tu-
mours is aimed at removal of the tumour and at the same time, as much 
as possible, minimise the possibility of recurrence. This entails radical 
surgery, which involves complete removal of the tumour by resecting the 
diseased part of the bone together with a 1 to 2-centimetre margin of 
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healthy looking bone.9,15,29,54 Treatment in such cases results in big de-
fects, which incapacitate the patients functionally and emotionally when 
not properly reconstructed. 
The majority of the odontogenic tumours are found in the mandible as 
compared to the maxilla. Due to its complex anatomy in relation to the 
other surrounding structures the maxilla, when affected by odontogenic 
tumours, often poses an even greater challenge in management com-
pared to the mandible. The more aggressive tumours like ameloblastoma 
and myxoma easily invade neighbouring structures and may infiltrate 
zones with vital structures like the orbit, base of the skull and the neck 
making treatment aimed at eradicating the tumour more compli-
cated.2,7,20,24-26,55,65,66,76 
Malignant odontogenic tumours are rare, however, their occurrence as 
primary tumours or when developing in existing odontogenic tumours im-
plies another challenge in management. Surgery alone may not suffice 
and a combination of surgery and radiotherapy may be more successful 
than single treatment.13,28 
 
Considerations with regard to reconstruction 
 
Since most tumours have reached a considerable size at the time the pa-
tients report to hospital many patients have to undergo continuity resec-
tions of the mandible or partial maxillectomies. It is particularly the hemi-
mandibulectomy or resections including the symphysis of the mandible 
that leave the patient a facial cripple, if reconstruction is not done. Quality 
of life (QOL) studies carried out in Western countries mainly on patients 
who underwent resections because of oral cancer, point towards unac-
ceptable invalidation when partial mandibulectomies are carried out.52 
The difference with patients undergoing resections for relatively benign 
but yet, aggressive odontogenic tumours is, however, twofold. First, pa-
tients with odontogenic tumours are usually much younger. They are of-
ten in the beginning of their professional career or have young families to 
take care of. Facial disfigurement often precludes normal social func-
tioning, which in Tanzanian circumstances may be rather gruesome. Ob-
jective data on the QOL in this patient group, however, is lacking. It would 
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be helpful to have these data to substantiate the need for reconstruction 
in selected cases. 
Second, in most cases tumour resection includes bony resections, but the 
soft tissue including muscles, nerves, mucosa and skin can usually be 
preserved. This makes the case for reconstruction somewhat easier as 
compared to the patient suffering from oral squamous cell carcinoma, 
who requires soft and hard tissue reconstruction. 
In the Tanzanian circumstances reconstructions were hitherto limited to 
rearrangement of muscles of the floor of the mouth and closure of mu-
cosa and skin. Patients would follow a rigid regime of exercises to learn to 
open and close their mouth more or less in a straight fashion. Jaw func-
tion, of course, is largely hampered, depending on the size of the re-
sected part of the mandible.  
Studies on reconstruction of the mandible after ablative surgery using 
autogenous bone grafts and platelet rich plasma (PRP) with rigid pre-
shaped plates has been going on in different areas showing promising re-
sults.16,31,33,63,64,70,71 Concentration of growth factors in PRP plays an im-
portant role in this technique.31,53 
In 1999, at the onset of this study, a reconstructive technique was intro-
duced in Dar es Salaam in which the resected part of the mandible was 
immediately replaced. The technique was a modification of the method 
introduced by Marx et al.. in 1998.31 It entailed the use of pre-shaped 
2.3mm titanium plates, autogenous bone grafts from the iliac crest and 
PRP. This reconstructive technique underwent some further modification 
because of studies of Fennis et al.. and Merkx et al.. in 2002 to 2004 who 
carried out various experiments in the same time period of this 
study.16,17,33 This technique, if successful, would meet the demands of 
less developed and economically deprived countries, because it does not 
require much time, whilst it is affordable when compared to repairs based 
on microvascular tissue transfers. It also would meet the specific needs 
because in patients with odontogenic tumours the soft tissues are usually 
not resected. 
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Relevance of the study 
 
Tanzania has a lack of specialised oral-maxillofacial surgical care with 
only two oral and maxillofacial surgeons in the whole country, who are 
stationed at the capital city. It is, therefore, near to impossible for most of 
the patients, who suffer from oro-facial lesions, to get specialist care in 
time. The cumbersome referral system, the distances one has to travel to 
reach the appropriate centre and the costs involved are some of the ma-
jor reasons that make that patients report late. With such constraints, 
careful planning to render the required service to those who are in dire 
need should be based on sound estimations of the needs. This implies 
that there is a need to quantify the problem and also to differentiate be-
tween the various tumours because each type requires a different ap-
proach to treatment. 
For the Tanzanian government these data are mandatory in order to plan 
on the training of manpower and on the distribution of oral and maxillofa-
cial surgery services so that they become available to the majority of the 
people. 
It has been suggested in the literature that ameloblastomas tend to occur 
more often in Blacks as compared to Caucasians.3,50,57 Although different 
authors have come up with different explanations for this seemingly 
higher incidence in Blacks,36 no scientific proof has so far been made 
available. A prospective study would clarify this issue. 
The average age of patients presenting with ameloblastoma have also 
been reported to differ showing that this tumour is affecting a much 
younger population in Africa as compared to European countries.47,49 This 
is another fact that has not found a clear explanation. 
In 1971 the World Health Organisation (WHO) issued a classification of 
odontogenic tumours, which was revised in 1992.27 This classification 
provides a means to carry out research on the epidemiology, clinical 
presentation and relative frequency of odontogenic tumours in an orderly 
fashion and makes comparison among different studies possible. It sim-
plifies identification, management and communication on matters related 
to such tumours. There is no study that has been done in Tanzania on 
odontogenic tumours in the context of this new classification. 
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The need for affordable reconstruction techniques hardly needs any fur-
ther explanation. If the technique used would be successful, a large group 
of patients could benefit from this. It would not only be applicable in de-
veloping countries but also in developed countries for a selected group of 
patients. 
 
Objectives of the study 
 
The general objectives of this study were to investigate the relative fre-
quency and incidence of the different odontogenic tumours in the Tanza-
nian population and to study the quality of life of patients who underwent 
ablative surgery for these tumours. It was also an objective to assess the 
success of a reconstruction method of the mandible after ablative sur-
gery, using autogenous particulate bone and platelet rich plasma. The 
following specific questions were formulated: 
• What is the relative frequency of odontogenic tumours among 
Tanzanians in relation to other tumours in the oro-facial region? 
• What is the prevalence and incidence of odontogenic tumours and 
what are the clinical and pathological characteristic features? 
• What is the incidence of odontogenic myxoma and what are the 
typical clinical, radiographic and pathological features? 
• What is the quality of life of patients who underwent ablative sur-
gery for aggressive odontogenic tumours without reconstruction? 
• Is it possible to primarily reconstruct patients undergoing ablative 
surgery due to odontogenic tumours with relatively simple means? 
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Abstract 
 
Objective: To retrospectively document the pattern of occurrence of 
odontogenic tumours in Tanzania over fifteen years.  
Design: The histologic types, site, age and sex distribution of odontogenic 
tumours in Tanzania from 1982 to 1997 were reviewed. Records of pa-
tients who presented to the four referral centres in Tanzania and who had 
histologically proven oral tumours and tumour-like conditions, were exa-
mined.  
Result: Odontogenic tumours comprised about 12.2% of all oral tumours 
and tumour-like conditions. The majority of odontogenic tumours (55.3%) 
were seen in patients below 30 years of age and they more commonly 
affected the mandible than maxilla. Ameloblastoma was the most com-
monly seen odontogenic tumour (73.7%), followed by odontogenic 
myxoma (10.3%). The site, sex, and histologic distribution of ameloblas-
toma did not differ from other African studies. Over 50% of patients with 
ameloblastoma presented to hospital late (after three or more years)  
Conclusion: In order to improve on the treatment outcome, the need for 
early detection and referral of patients by medical personnel and dentists 
in stressed.  
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Introduction 
 
Odontogenic tumours form a group of lesions essentially occurring in the 
mandible and maxilla, but on very rare occasions may be found in other 
sites.1-6 They are classified according to the World Health Organization’s 
Histological Typing of Odontogenic Tumours.7 Their natural history varies 
widely1 and generally there are no known aetiological factors. Odonto-
genic tumours constitute about 0.002% of all neoplasms,8 between 1.11 
and 1.3% of all oral biopsy specimens1,9 and between 2.5 and 15% of all 
oral neoplasms.10,11 There are only a few reports available on the relative 
frequencies of odontogenic tumours, the incidence of the various his-
tologic types and the geographic and racial distribution.6,9,10,12-17 The ma-
jority of them are true benign odontogenic tumours, however, occasionally 
malignant variants are encountered.  
Ameloblastomas, although benign in nature, tend to invade tissues locally 
and this makes them prone to recurrence. A neoplasm in which both the 
patterns of an ameloblastoma and cytological features of malignancy are 
shown by the primary growth in the jaws and/or by any metastatic growth 
is called a malignant ameloblastoma.18 While the ameloblastoma has 
been found to be the most common odontogenic tumour in Africa and 
Asia, this is different in Germany, The United States, Canada and Mexico 
where the most common odontogenic tumour was odontoma.1,6,9,12,13,14,17 
Two studies suggest a possible higher incidence rate of ameloblastomas 
in black Africans.19,20 In Tanzania Slavin and Cameron15 found the rela-
tive frequency of ameloblastoma to be 0.7%. This figure may, however, 
be misleading because in their study they calculated this on the basis of 
the frequency of malignant tumours.  
Shear and Singh,20 based on an age-standardized study among South 
African Blacks and Whites, concluded that the incidence rate of 
ameloblastomas was much higher among Blacks than Whites, that is 
1.96, 1.20, 0.18 and 0.44 for Black males and females, and White males 
and females respectively. Larsson and Almeren21 in Sweden, estimated 
the incidence rate of ameloblastoma to be 0.6 per million and Muller22 in 
the Netherlands reported a similar figure.  
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Only a few East African Studies on the relative frequency and incidence 
rate are available.15,16,23 Unfortunately, the epidemiological terms used 
were often confusing making it very difficult to extract reliable figures for 
comparison. In order to be able to plan on the number of specialist cen-
tres that are able to treat these rather devastating tumours, it seemed 
prudent to make an inventory in Tanzania about the potential needs. It is, 
therefore, the aim of the present study to determine the relative frequency 
and incidence rates of different odontogenic tumours in the Tanzanian 
population over a fifteen-year period and to compare this data with those 
from studies in other parts of the world.  
 
Material and methods 
 
The medical records of patients with oral tumours attending the four refer-
ral centres in Tanzania, Bugando Medical Centre (BMC), Kilimanjaro 
Christian Medical Centre (KCMC), the Muhimbili Medical Centre (MMC) 
and Mbeya Referral Hospital (MRH) over a fifteen-year period (1982 to 
1997) were reviewed. Most patients with oro-facial tumours were usually 
referred to these centres where biopsies were taken and delivered to 
MMC or KCMC histopathology laboratories for histological examination. 
The records from these centres, therefore, are closely representative of 
the whole of the Tanzanian population. The reports of the histologic ex-
aminations of biopsies taken from the patients and the files of the patients 
formed the only source of information.  
 
Results 
 
Twenty-eight patients’ files were not available for re-examination, which 
implies that the location and size of the tumour was not known but infor-
mation on sex, age and histology were known through the histology re-
ports. In 37 of the cases the specific age was not known because it was 
only indicated as either adult or child. The different tumours and tumour-
like lesions encountered in this study are shown in Table 1. 
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Table 1: Distribution of different oro-facial tumours or tumour-like lesions 
seen in Tanzania from 1982-1997. 
 
Tumour N
Ameloblastoma   
Squamous cell carcinoma  
Kaposi’s sarcoma   
Burkitt’s lymphoma   
Epulis    
Pleomorphic adenoma 
Fibrous dysplasia 
Haemangioma 
Malignant lymphoma 
Fibroma 
Adenocystic carcinoma 
Ossifying fibroma 
Radicular cyst 
Odontogenic myxoma 
Papilloma 
Other odontogenic cysts 
Other cysts 
Mucocele 
Dentigerous cyst 
Dermoid cysts 
Odontogenic keratocyst 
Others  
Non specified 
157
152
148
137
56
56
46
43
30
29
29
28
22
22
21
20
16
16
14
11
7
421
271
Total  1752
 
Except for the odontogenic keratocyst, all the tumours and tumour-like le-
sions of which the total number in the whole study was less than ten (for 
example, malignant melanoma, verucous carcinoma, chodromyxoid fi-
broma and haemongio-endothelioma) were grouped together as “others”. 
Those tumours for which a definite histologic diagnosis could not be 
made were categorized as non-specified. Odontogenic tumours com-
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prised only 12.1% of the total number of oro-facial tumours. Ameloblas-
toma appeared to have been the most common odontogenic tumour fol-
lowed by odontogenic myxoma and odontomas. Table 2 shows the distri-
bution of the different types of odontogenic tumours by sex. Males and 
females were almost equally affected.  
Table 3 shows the distribution of the odontogenic tumours by site. Most 
tumours occurred in the mandible (90.2%) as compared to the maxilla 
(9.7%). The location of ameloblastomas in the mandible was most often 
in the posterior region, that is, premolar-molar-ramus region (62.4%). 
Some of these tumours, however, extended to the anterior area or even 
occupied the whole horizontal part of the mandible (13.8%) and the re-
maining tumours were located solely in the anterior part from canine to 
canine (23.8%). 
Table 4 shows the distribution of the odontogenic tumours by age. The 
age range was from 7 to 71 years (Table 4).  
More than half (55.3%) of the patients who presented with odontogenic 
tumours were below 30 years of age. Ameloblastomas most often af-
fected patients in the ages between 20 and 40 years.  
 
Table 2: Distribution of odontogenic tumours by sex. 
 
Tumour Male Female Total % 
Ameloblastoma 76 81 157 73.7
Odontogenic myxoma 9 13 22 10.3
Cementoma 8 3 11 5.2 
Odontoma:  Compound  2 4 6 2.8 
                    Complex 3 2 5 2.3 
Calcifying epithelial odontogenic tumour 1 2 3 1.4 
Squamous odontogenic tumour 2 0 2 0.9 
Adenomatoid odontogenic tumour 0 2 2 0.9 
Ameloblastic fibroma 2 0 2 0.9 
Cementifying fibroma 1 1 2 0.9 
Calcifying odontogenic cyst 0 1 1 0.5 
Total 104 109 213 100 
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Table 3: Distribution of odontogenic tumours by site. 
 
Maxilla Mandible Tumour 
Ant. Post. Ant. Post. 
Both  
Ant./Post.
Ameloblastoma 3 9 24 63 14 
Calcifying epithelial odontogenic 
tumour 
- - - 3 - 
Squamous odontogenic tumour - - - 2 - 
Odontoma : Compound - 1 - 5 - 
                    Complex - 1 1 3 - 
Adenomatoid odontogenic tumour - - 1 1 - 
Calcifying odontogenic cyst - 1 - - 0 
Ameloblastic fibroma - - 1 1 - 
Cementifying firbroma - - 2 - - 
Cementoma - - 1 10 - 
Odontogenic myxoma 3 4 3 9 2 
Total 6 16 33 97 16 
N.B.: 
1. In three cases of ameloblastoma it was not stated which jaw was  
 affected. 
2. In 38 cases of ameloblastoma of the mandible and three cases of 
the maxilla the exact location in the jaws was not stated. 
3. The location of one odontogenic myxoma was not stated. 
 
Histomorphologically, the majority of the ameloblastoma diagnosed were 
of follicular pattern (38.2%) followed by plexiform (27.4%) and unicystic 
type (5.1%). The remaining 29.3% were diagnosed as ameloblastoma 
without further characterization. Most patients with ameloblastoma had 
clinical signs and symptoms for more than a year before reporting to hos-
pital. About one third of the patients presented within the first three years 
after the onset of signs and symptoms, but a considerable number of pa-
tients presented much later (Table 5). Based on the population of Tanza-
nia (31 million), an incidence rate of odontogenic tumours of 0.4 per mil-
lion and ameloblastoma of approximately 0.3 per million can be calcu-
lated.  
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Table 4: Distribution of odontogenic tumours by age. 
 
Tumour Age in years 
 0-
9
10-
19
20-
29
30-
39 
40-
49 
>50
Ameloblastoma 3 16 42 22 20 17 
Calcifying epithelial odontogenic 
tumour 
0 0 0 2 1 0 
Squamous odontogenic tumour 0 0 1 1 0 0 
Odontoma Compound 1 4 1 0 0 0 
Complex 0 2 2 1 0 0 
Adenomatoid odontogenic tumour 0 1 1 0 0 0 
Calcifying odontogenic cyst 0 0 1 0 0 0 
Ameloblastic fibroma 0 2 0 0 0 0 
Cementifying fibroma 0 1 1 0 0 0 
Cementoma 0 1 1 0 0 0 
Odontogenic myxoma 0 5 10 6 1 0 
Total 4 32 60 32 22 17 
N.B.: In 46 patients with odontogenic tumours the age was not specified but was re-
corded as adult or child only. 
 
Table 5: Time elapsed between the appearance of first signs and symp-
toms in patients with ameloblastoma and the time of presenting to hospi-
tal 
 
Years N % 
0 - 1 
2 - 3 
4 - 5 
6 - 7 
8 - 9 
10 - 11 
12 - 13 
14 - 15 
>15 
Unspecified 
23 
54 
27 
10 
5 
3 
2 
3 
2 
28 
14.6 
34.4 
17.2 
6.4 
3.2 
1.9 
1.3 
1.9 
1.3 
17.8 
Total 157 100 
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Discussion 
 
This study focused on the relative frequencies of the different odonto-
genic tumours and the incidence rates of ameloblastoma as seen in Tan-
zania over a fifteen-years period. The fairly large group of non-specified 
tumours forms a serious flaw in this retrospective study. One reason may 
be that some of the specimens may not have been representative of the 
lesions removed. It cannot be ruled out, however, that a number of these 
tumours in fact were odontogenic tumours, which may have lowered the 
total number of odontogenic tumours found.  
Odontogenic tumours formed a relatively small proportion of orofacial tu-
mours seen during this period comprising only 12.2%. This is in keeping 
with available African reports, which have shown relative frequencies of 
odontogenic tumours among all different orofacial tumours to vary be-
tween 2.5 and 19.1%.5,11,24 Among odontogenic tumours, ameloblastoma 
was most commonly seen with a relative frequency of 73.7%. This is also 
in keeping with most African studies. Chidzonga et al..25 in Zimbabwe re-
ported a relative frequency of 78%, while Odukoya et al..5 and Mosa-
domi11 reported relative frequencies of 58.5% and 65.5%, respectively in 
Nigeria. Asian studies have presented similar figures. In China, Lu et al..6 
and Wu and Chan17 found relative frequencies of ameloblastoma of 
58.6% and 45%, respectively. In Turkey, although the relative frequency 
of ameloblastoma was slightly lower than in the African and Asian studies 
it also ranked highest among odontogenic tumours with a relative fre-
quency of 36.5%.12 These figures differ from European and American 
studies, which reported relative frequencies between 10% and 23.7%, 
second to odontoma, which was the most common odontogenic tu-
mour.1,9,13,14 
It is apparent from these figures that the relative frequencies of 
ameloblastoma as found in Africa and Asia are the highest. Racial predi-
lection, as proposed by Sawyer et al..19 has been disputed by others who 
have attributed this higher relative frequency in Africans to a “harvesting 
effect”.11 Tumours other than ameloblastoma and myxofibroma may also 
reach considerable size but will still present little discomfort to the patient 
which precludes him/her to seek medical treatment. Ameloblastomas and 
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myxofibroma, however, usually present with more disfigurement causing 
problems, which actually forces the patient to present to hospital. It is also 
likely that the readily available dental services in American and Western 
European countries, where oral radiographic examinations are done on a 
routine basis, accounts for early detection of jaw tumours such as odon-
tomas that to a large extent are symptomless. This is supported by the 
results of this study.  
From this study it is clear that many patients with ameloblastoma in Tan-
zania presented themselves to the hospital after considerable delay (Ta-
ble 5). The time that elapsed between the appearance of clinical signs 
and symptoms and reporting to hospital ranged from one year to more 
than fifteen years in some cases. In one case a woman reported to have 
had the tumour for 22 years. In addition, due to pressing socio-economic 
priorities in many instances patients tend to go to hospital only when 
there is unbearable pain, discomfort or gross interference with function. In 
the Tanzanian society oral health is also given a low priority compared to 
more life threatening medical conditions such as AIDS, malaria and mal-
nutrition. Other factors that might have contributed to the delays are the 
distances one had to travel to the appropriate centre and the financial im-
plications, the introduction of cost sharing (user fees) in the health sector 
in recent years, ignorance of patients and failure of health workers at pri-
mary health facilities to diagnose and refer patients.26 
Histologically, like in other studies,1,5,11,17 the follicular type of ameloblas-
toma dominated followed by the plexiform type. None of the other types 
were reported. During most of the period covered in this study there was 
no oral pathologist in Tanzania, therefore, the biopsy specimens were 
examined by general pathologists. This may be the reason why more 
rarely encountered histologic types of ameloblastoma such as the 
desmoplastic, malignant, basal cell or granular cell types were not 
reported. There is also a possibility that some unicystic ameloblastomas 
were diagnosed and treated as odontogenic cysts on the basis of clinical 
and radiological findings.  
Only 9.7% of the ameloblastomas were located in the maxilla, 90.3% 
were in the mandible and in three patients it was not stated whether they 
were maxillary or mandibular. This is in keeping with other studies done 
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elsewhere.5,6,12,17,25 The equal distribution of ameloblastomas between 
males and females is also in agreement with available data from other 
studies.6,12,16,17 The clinical presentation of ameloblastoma by site does 
not differ from other studies either. Similar findings have been re-
ported.5,6,14,17,25,27 However, it differs from other studies24,28,29 where 
ameloblastoma was found to be located in the anterior part more often 
than in other parts of the mandible.  
The calculated incidence rate of ameloblastomas in Tanzania seems 
somewhat low in the light of the suggested higher rates among African 
blacks. Some of the cystic ameloblastomas, however, have probably 
been removed without histological examination, which would affect the 
reported numbers in an unfavourable way. It is also likely that some pa-
tients may have been operated in some regional hospitals without input 
from the oral-maxillofacial surgeons, while some patients may have re-
fused treatment in the referral centres.  
Odontogenic myxoma was the second most commonly seen odontogenic 
tumour. Odukoya5 in Nigeria, and Lu et al..6 in China also found myxoma 
to be the second most commonly seen odontogenic tumour after 
ameloblastoma with relative frequencies of 11.8% and 8.4%, respectively. 
In Turkey, although it came third after ameloblastomas and odontomas, 
odontogenic myxomas have a higher relative frequency (13.8%). Of the 
22 myxomas seen, the majority were located in the mandible, nine of 
them posteriorly. This is in keeping with the present knowledge that 
odontogenic myxoma has a predilection for the mandible.30 The majority 
of odontogenic myxomas were found within the age of 20 to 40 years and 
none was found in children below the age of ten years. This compares 
with available literature.27 
The relative frequency of odontomas, both compound and complex 
variants was 5.2% and the majority were located in the posterior man-
dibular region. This low frequency contrasts with studies from Europe and 
America9,13,14,19 but is in keeping with other African and Asian studies.5,6,25 
There was an almost equal sex distribution and they were seen mostly 
between the ages of 10 to 30 years. Cementoblastoma was seen with the 
same relative frequency as that of odontomas also with a predilection for 
the mandible.  
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Ameloblastic fibroma, cementifying fibroma, squamous odontogenic tu-
mour and adenomatoid odontogenic tumour (AOT) were all seen with a 
relative frequency of about 0.9%. Of these the AOT was seen in two fe-
males in their early twenties. This particular tumour had been seen with 
higher frequencies in Nigeria, 6.2%, Mexico 7.1%, China 8.3%, German 
4%, Canada 3.6%, and United Stated 3.4%.1,5,6,9,13,14 The low relative fre-
quency of most of these tumours, as seen in this study, is probably attri-
butable to the fact that they are largely symptomless unless they reach 
considerable size and, therefore, patients did not present themselves. It is 
also possible that the specimens were not always sent for histologic 
examination, because of the obvious benign nature. Since expert histopa-
thologic service was only available at the MMC during most of the period 
covered in this study, clinicians were not encouraged to submit speci-
mens to avoid the cumbersome procedures involved in obtaining results.  
The extremely low relative frequency of odontogenic keratocysts can 
probably be explained by a “reversed harvesting effect”. It is known that 
the majority of keratocysts give rise to very few signs and symptoms such 
as swelling and pain. These cysts tend to hollow out the mandible instead 
of giving rise to expansion.31 They also tend not to be easily infected. In 
the Tanzanian circumstances this means patients do not see the need for 
medical treatment unless acute inflammatory reaction or pathologic frac-
tures force them to report for treatment.  
Ameloblastomas formed the majority of odontogenic tumours in this 
study. The peak age of ameloblastoma was between 20 and 29 years. 
Many of the patients reported to hospital late with large tumours that had 
already caused gross bone destruction. In order to get better treatment 
results, there is need to educate the population on the nature of the le-
sions and advantages of early treatment. The dentists and medical per-
sonnel can facilitate this through early detection and referral of the pa-
tients. A prospective study with the intention to categorise the various tu-
mours more precisely and to calculate the incidence rate more accurately 
is recommended.  
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Abstract 
 
This study, conducted between 1999 and 2003, included all patients with 
odontogenic tumours referred from all dental clinics and other health fa-
cilities in Tanzania to the only 4 referral centers. Demographic data and 
clinical and histopathological findings were recorded. Histopathological 
specimens were examined by expert pathologists. 
Ameloblastoma had the highest relative frequency (80.1%) and an inci-
dence rate of 0.68 per million, followed by odontogenic myxoma (7.0%) 
with an incidence rate of 0.07 per million. Follow-ups of between 6 
months and 4 years were carried out. Two patients developed recur-
rences of ameloblastoma.  
The incidence of ameloblastoma in this exclusively black African popula-
tion did not differ from that of European countries. This is contrary to the 
belief that ameloblastoma has a higher incidence in black Africans as 
compared to Caucasians.  
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Introduction 
 
Despite several retrospective studies carried out in Africa, Asia, Europe 
and North America,1-10 there are still unanswered questions in relation to 
the relative frequency and incidence of some odontogenic tumours. There 
is, for instance, a hypothesis that ameloblastomas occur more frequently 
in black Africans as compared to other races.11,12 If this hypothesis is true, 
the higher incidence would require an investigation as reasons are not 
clearly understood.  
A retrospective study carried out in Tanzania over a 15 years period re-
vealed that ameloblastoma was the most frequently encountered tumour 
in the maxillofacial area, even more often seen than squamous cell carci-
noma.13 Among odontogenic tumours ameloblastoma was by far the most 
frequently observed tumour, ie, 157/213 (73%). Yet, when calculated over 
the total population of Tanzania the incidence rate was only 0.3 per mil-
lion. This is even lower than the incidence rate as reported in several 
European and North American studies.14-16  
In order to ascertain a realistic incidence, it was thought to be necessary 
to carry out a prospective study on odontogenic tumours, thereby calcu-
lating the incidence of the various odontogenic tumours over a 4-year pe-
riod.  
 
 
 
Fig. 1: A patient with a large ameloblastoma of the mandible. She re-
ported to hospital after a history of swelling of more than 21 years 
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This epidemiological study could be the basis for the planning of treat-
ment centres as well as for training of health professionals. Furthermore, 
it could be used to educate health professionals and the public in general 
against unnecessary delay in reporting to hospital, which is one of the 
most prominent problems with regard to oral-maxillofacial tumours in 
most Third World countries (Fig. 1).2,4,5,13 
The aim of this study was, therefore, to determine the incidence and clini-
cal presentation of different odontogenic tumours in Tanzania 
 
Material and Methods 
 
This prospective study was carried out from January 1999 till January 
2003. All patients with tumours and tumourlike lesions that were either 
clinically or radiologically or both clinically and radiologically suspected to 
be of odontogenic origin and who were seen at the dental departments of 
all district, regional and zonal referral medical centres in Tanzania were 
ultimately referred to the Oral Surgery and Oral Pathology department of 
the Muhimbili National Hospital in Dar es Salaam. This was done after re-
peated and thorough instructions to dental professionals in all the regional 
dental clinics and the 4 zonal referral centers in the country. During this 
study the first author visited these referral centers at least twice so as to 
ascertain maximum cooperation.  
The patients were clinically and radiologically examined. Biopsies were 
taken and the specimens were submitted to the Department of Pathology 
of the Muhimbili University College of Health Sciences and the Depart-
ment of Oral Pathology of the Free University Teaching Hospital Amster-
dam, The Netherlands. Slides were stained with hematoxylin and eosin 
(H&E) and examined under light microscope by experienced oral pa-
thologists. The histological diagnosis of the individual tumours was based 
on the 1992 World Health Organization (WHO) classification of odonto-
genic tumours.17  
The independent opinions of two pathologists were compared to reach 
the final diagnosis. Every patient’s treatment was planned according to 
the diagnosis. Surgery included conservative removal of the lesion in 
case of benign nonaggressive tumours like ameloblastic fibroma or 
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odontoma to radical excision of the tumour with a margin of healthy bone 
in aggressive tumours like ameloblastoma or myxoma. Some selected 
patients with ameloblastomas, depending on the size of the tumour, were 
treated by resection of the mandible and immediate reconstruction. 
Where possible, patients were followed up for a period of between 1 and 
4 years. Informed consent was obtained from all the patients who were 
included in the study. 
 
Results 
 
A total of 116 patients with odontogenic tumours were seen during this 
four-year period. Ameloblastoma was seen with the highest frequency 
(80.1%) followed by odontogenic myxoma (7%) (Table 1). Based on the 
population of Tanzania of 34 million, the calculated incidence rate of 
ameloblastoma found in this study was 0.68 per million per year while that 
of odontogenic myxoma was 0.07.18  
 
Table 1: The frequency of occurrence of different odontogenic tumours. 
 
 Tumour No. % 
1 Ameloblastoma 93 80.1 
3 Odontogenic myxoma 8 7.0 
4 Odontoma 3 2.6 
4 Odontogenic fibroma 2 1.7 
5 Calcifying odontogenic cyst (Gorlin cyst) 2 1.7 
6 Calcifying epithelial odontogenic tumour (CEOT) 2 1.7 
8 Ameloblastic fibroma 2 1.7 
9 Cementoblastoma 2 1.7 
10 Adenomatoid odontogenic tumour (AOT) 1 0.9 
11 Clear cell odontogenic carcinoma 1 0.9 
 Total 116 100% 
 
Distribution of the different tumours by age and gender is shown in Table 
2. Most (71%) patients with odontogenic tumours were in the age group 
of 10 to 39 years with a mean of 32 years. Ameloblastoma had an equal 
distribution between males and females and occurred with a mean age of 
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35 years. Histologically the follicular type of ameloblastoma was the most 
common (51.6%) followed by the plexiform type (23.6%). There were 9 
patients (9.6%) who had unicystic ameloblastoma with an age range of 15 
to 50 years (mean 27 years).  
 
Fig. 2: Locations of the 90 mandibular ameloblastomas. 
1. Tumour extending from right condyle to left condyle (10%) 
2. Tumour extending from the right ramus crossing the midline to in-
volve the body on the left side (10%) 
3. Tumour extending from the right ramus to the midline (18.9%) 
4. Tumour localized in the right ramus (4.4%) 
5. Tumour occupying the symphysial region only (21%)  
6. Tumour localized in the left ramus (2.2%) 
7. Tumour extending from left ramus to the midline (24.9%) 
8. Tumour extending from left ramus crossing the midline to involve 
the body on the right side.  
N.B. Mandibular ameloblastomas were located in all anatomical parts of 
the mandible with the majority (44%) seen in the body/angle/ramus region 
both left and right side.  
 
The distribution of ameloblastomas according to location in the mandible 
is shown in Fig. 2. Forty-three percent of all ameloblastomas were located 
in the body – ramus region of the left or right side of the mandible. 
Twenty-one percent occurred in the symphysis only, another 30%, how-
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ever, occupied not only the symphysis but also other parts of the mandi-
ble. Over 40% of ameloblastomas demonstrated clear root resorption. 
Clinically, only a few of the patients presented with symptoms other than 
a slow growing swelling. Pain was not a common feature in patients with 
odontogenic tumours. However, there were 19 patients (20.4%) with 
ameloblastoma who presented with mild to moderate pain and only 7 pa-
tients (7.5%) had paraesthesia of the inferior alveolar nerve. Paraesthesia 
was also present in 1 odontogenic myxoma patient. A total of 51 patients 
with ameloblastoma were followed up, at least once after treatment for 
periods ranging from 6 months to 4 years, out of whom only 2 patients 
with ameloblastoma were found to have a recurrence.  
 
Discussion 
 
This study was conducted after raising the awareness of the dental pro-
fessionals at the district, regional and zonal referral medical centres. This 
was necessary to ascertain the highest possible level of cooperation in 
order to get accurate data on the magnitude of odontogenic tumours in 
the Tanzanian population. Despite this fact, we are acutely aware of the 
deficiencies that are inherent to hospital-based studies that might have 
influence on these results. Some of these shortcomings are:  
1. some people in the communities suffering from odontogenic tu-
mours might not have reported to hospital at all for different rea-
sons; 
2. some who reported to hospital refused to undergo proper investi-
gations and, therefore, the final diagnosis was not reached; 
3. some of the patients who were referred might have failed to meet 
the costs involved; 
4. in a few cases the diagnoses might have been technically 
impossible in which case these were left out of the study.   
 
Nevertheless, the results from this prospective study should be as accu-
rate as possible under the given circumstances and should provide rea-
sonable reliable data. If anything, considering the above factors, the inci-
dence rates of each tumour may be slightly higher.  
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Table 2: The distribution of odontogenic tumours by age and gender. 
Type of tumour Age and gender 
 0 – 9 10 – 19 20 – 29 30 – 39 40 – 49 50 – 59 > 60 Total 
M F M F M F M F M F M F M F No %
Ameloblastoma     1 151 145 149 11 6 6 2 4 4 1 93 80.1
Odontogenic myxoma                 3 2 1 1 1 8 7.0
Odontoma                 1 1 1 3 2.6
Calcifying odontogenic cyst (Gorlin cyst)   1   1         2 1.7 
Calcifying epithelial odontogenic tumour (CEOT)          1  1   2 1.7 
Odontogenic fibroma     1       1    2 1.7 
Ameloblastic Fibroma                 1 1 2 1.7
Cementoblastoma                 1 1 2 1.7
Adenomatoid odontogenic tumour        1       1 0.9 
Clear cell odontogenic carcinoma         1      1 0.9 
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 Most of the studies carried out on odontogenic tumours were retrospec-
tive in design. In some studies the epidemiological terminology was in-
advertently used; in several cases incidence was interchangeably used 
as opposed to relative frequency and in many only relative frequency 
was calculated.2-10,19 The present study is prospective and, thus, forms a 
good basis for reliable data on odontogenic tumours because it provided 
an opportunity for active surveillance of the patients with tumours, which 
is impossible in retrospective studies. 
Of the odontogenic tumours ameloblastoma occurred with the highest 
frequency (80.1%) followed by odontogenic myxoma (Table 1). This 
relative frequency is higher than that obtained from the retrospective 
study (73%).13 The incidence rate of ameloblastoma as found in this 
study, however, is in fact similar to that reported from European coun-
tries.14,15 This casts doubt on the long-held opinion that ameloblastomas 
might be occurring with a higher frequency in black Africans as com-
pared to Caucasions.11,12 The reasons for the high relative frequencies 
as seen in many African countries were explained in our previous 
study.13 In short, the fact that patients present to hospitals only when 
they have incapacitating symptoms is the main reason for the seemingly 
high frequency of some of the odontogenic tumours. Other contributing 
factors include unavailability of facilities for proper investigations and 
delayed diagnosis at primary centres.  
Odontogenic tumours have been reported to occur at younger ages in 
Africa than elsewhere.19 In this study the average age coincides with 
those from European studies, but, one has to keep in mind that patients 
in Tanzania report to hospital late, often with history of several years. 
This means that many of the patients’ ages at the commencement of the 
disease were less than the ones on record.  
The distribution of the various types of ameloblastomas (Table 3) is not 
different in this study from the results reported by others.5,11,15,20 The re-
ported significantly higher recurrence rate of the follicular type20 was not 
seen in the present study but the follow-up in this study has been fairly 
short.  
Ninety-seven per cent of the ameloblastomas were located in the man-
dible compared to 3% that were located in the maxilla. Though the latter 
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 are few, ameloblastomas of the maxilla pose special difficulties regar-
ding treatment. 
The mere fact that Tanzanian and indeed most African patients present 
late (Fig. 1), with large tumours and that surgery often entails resection 
of tumour including part of healthy bone, leaves the patients with big 
defects and a high degree of disfigurement.  
Mandibular ameloblastomas were located in all anatomical parts of the 
mandible with the majority (44%) seen in the body/angle/ramus region 
both left and right side (Fig. 2). This makes it difficult to compare with 
findings from others because it is often not specified whether tumours 
occupied more than one region. It is, therefore, not possible to confirm 
the suggestions, as appears in the literature, that the symphyseal region 
is more often affected in black Africans.11,21,22 
 
Table 3: Distribution of Ameloblastomas according to histologic type 
 
Histologic type No % 
Follicular 48 51.6 
Plexiform 22 23.6 
Acanthomatous  6 6.4 
Granular 3 3.2 
Follicular + Plexiform 3 3.2 
Ameloblastic carcinoma 2 2.2 
Desmoplastic 2 2.2 
Basal cell 2 2.2 
Follicular + basal cell 1 1.1 
Follicular + squamous metaplasia 3 3.2 
Follicular + adenomatoid 1 1.1 
Total 93 100 
 
One has also to keep in mind that African patients have often long 
standing tumours. By the nature of that phenomenon they occupy large 
areas. In our study, for instance, some tumours occupied the whole 
mandible from condyle to condyle (Fig. 2). These large ameloblastomas 
pose several challenges in managing patients, including long and com-
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 plicated operations, which at times involved either disarticulating the 
mandible from both temporomandibular joints, or resection of large parts 
of the mandible. Reconstruction of the mandible to close the gap left af-
ter removal of the tumour is either difficult or sometimes impossible. 
Postoperative rehabilitation of the patients does not yield good results 
and often such patients lead miserable lives throughout because recon-
struction in the majority of them is impossible.23 
Two ameloblastic carcinomas were diagnosed. The malignant charac-
teristics of the primary tumour were mainly expressed by the cytological 
features and its relatively rapid growth. Neither regional lymph node in-
volvement nor metastases were observed.  
Odontogenic myxoma was the third most common tumour with a relative 
frequency of 7.0%. This low relative frequency is also reported by 
others.24 It usually appeared as a multilocular radiolucency without clear 
margins and in 3 cases a tooth was included within the tumour. The 
majority of the patients with odontogenic myxoma did not present with 
any complaints except for a few who had some pain, paraesthesia, bone 
perforation with soft tissue involvement and tooth mobility. The chal-
lenges that are faced in diagnosis and management of ameloblastomas 
in this part of the world are almost similar to those for myxoma. The 
usually similar clinical and radiological presentation of the 2 tumours i.e. 
large lesions occupying a large part of the mandible and the high ten-
dency of recurrence for both, if not well treated, implies extensive sur-
gery, which is a challenge in the Tanzanian circumstances. Adequate 
treatment of these benign but aggressive lesions entails resection with 
margins of at the least 1 cm healthy bone. This leaves usually big de-
fects that are difficult to reconstruct in this part of the world, because of 
economic constraints and lack of manpower.  
Other tumours seen in this study, with very low frequencies of between 
0.9% and 2.6% included odontomas, calcifying epithelial odontogenic 
tumours, cementoblastoma, ameloblastic fibroma, and adenomatoid 
odontogenic tumour. The newly recognized entity termed as clear cell 
odontogenic carcinoma was also encountered in this series. Though few 
cases have been published, this tumour seems to be more locally ag-
gressive than ameloblastoma and has histological similarities to clear 
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 cell adenocarcinoma. Proper diagnosis and management of this tumour 
is necessary.25,26  
The fact that most of odontogenic tumours remain painless throughout 
the course of the disease27 is the main reason why either patients do not 
present to hospital at all or only present when the tumours have reached 
enormous sizes (Fig 1).28,29 In the Tanzanian environment, where under 
normal circumstances, people do not undergo regular dental check-ups, 
this is probably the reason why such lesions are rarely detected early.  
In conclusion, in this 4 year prospective study ameloblastoma appeared 
to present with the highest frequency in Tanzania. However, the inci-
dence of this tumour does not differ from that reported from European 
studies. This cast doubt on the existing belief that ameloblastoma has a 
higher incidence in Africans as compared to Caucasians.11,12 Prospec-
tive studies on odontogenic tumours in various parts of the world are 
necessary to validate this finding. Late reporting by patients with odon-
togenic tumours is still a big problem that needs to be addressed in Tan-
zania and probably in many African countries. A well-planned awareness 
approach would probably be effective to encourage people to seek early 
treatment in case they develop tumours of the jaws. 
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 Abstract 
 
Odontogenic myxoma, a rare tumour that occurs in the jaws, has been 
reported to be the second commonest odontogenic tumour in many 
countries. Few studies, however, provide detailed clinicopathological 
findings of a large series of cases and no study so far has attempted to 
calculate the incidence of this condition. Retrospective and prospective 
studies were carried out in Tanzania from 1982 to 1998 (16 years) and 
1999 to 2002 (4 years), respectively. A total of 33 cases of myxoma 
were found with a male:female ratio of 1:1.83. Most of the tumours were 
located in the mandible compared to the maxilla and were predominantly 
multilocular. Pain, dysaesthesia, ulceration, invasion of the soft tissues 
and tooth mobility were among the symptoms that patients presented 
with although the majority had no clinical signs or symptoms.  
Based on the prospective study only, an annual incidence of 0.07 per 
million can be ascertained. Late reporting was a common feature in this 
group of patients. Radical surgery with resection of the tumour with a 
safe margin is advocated. 
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 Introduction 
 
Odontogenic myxoma (OM) is a non-encapsulated benign tumour of the 
jaws that occurs very rarely. It is a slow growing tumour consisting of an 
accumulation of mucoid ground substance with little collagen, the 
amount of which determines whether it can be called a myxofibroma. 
Only occasionally does odontogenic myxoma show the presence of 
odontogenic epithelium.9,17,18 
The origin of odontogenic myxoma is believed to be the mesenchyme of 
a developing tooth or the periodontal ligament.17,21,37 Some authors had 
previously associated its origin with a myxomatous change of an odon-
togenic fibroma18,35 or residual foci of embryonic tissue. Based on the 
information gathered from the available literature it is still somewhat ar-
guable whether odontogenic myxoma is truly an odontogenic neoplasm. 
However, its histological similarity to the stellate reticulum of a de-
veloping tooth, its exclusive occurrence in close proximity to the tooth 
bearing parts of the jaws, the occasional association with a missing or 
unerupted tooth, the presence of odontogenic epithelium in a minority of 
cases and the fact that it rarely appears in other parts of the body 
skeleton, offer support to an odontogenic origin.18,37 
There are only a few reports on the relative frequency and incidence of 
odontogenic myxoma in the available literature and also the numbers 
reported are low varying from 3–26.16,33 In Africa OM is seen to be the 
second commonest odontogenic tumour after ameloblastoma occurring 
with relative frequencies between 1 and 19%.1-5,22,27,28,32 In Asia, Europe 
and America relative frequencies between 0.5 and 17.7% have been re-
ported.8,12,19,23,30,39 None of these studies attempted to calculate the inci-
dence of odontogenic myxoma.  
The aim of the present study, therefore, was to determine the incidence 
and describe the clinicopathological presentation of a relatively large se-
ries of odontogenic myxomas in Tanzania over a period of 21 years and 
to compare this information with that available in the literature.  
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 Material and methods 
 
Since 1999 a prospective study has been carried out in Tanzania over a 
4-year period in which epidemiological data have been collected on 
odontogenic tumours. The results will be published elsewhere but the 11 
odontogenic myxomas from this study are included in this analysis. 
The files, radiographs and histopathology reports of patients with odon-
togenic tumours who attended the dental departments of the four referral 
centres in Tanzania; Muhimbili National Hospital (MNH), Mbeya Con-
sultant Hospital (MCH) and Bugando (BMC) and Kilimanjaro Christian 
Medical Centres (KCMC) from 1982 till 1998 were retrospectively re-
viewed. Twenty-two patients were identified, which adds up to a total of 
33 cases. In 21 cases all relevant data were available including age, 
gender and clinical data and the radiographic and histo-pathological re-
ports. Either the original histological slides were retrieved and examined 
or fresh slides were prepared from the wax blocks that were kept in file. 
The slides were stained with haematoxylin-eosin and examined by an 
experienced oral pathologist (EV). The clinical information included the 
period of time that the tumour was noted, size, site and presence of 
other accompanying symptoms such as pain, tooth displacement, 
paraesthesia or ulceration. Radiological features regarding size and 
shape of the lesion, border definition and state of the surrounding bone 
and teeth were reported. Twelve patient’s files and radiographs from the 
retrospective study could not be retrieved for review. Information on 
these patients regarding age, gender, site and histological type of tu-
mour was available, through the written pathology reports. 
 
Results 
 
A total of 33 odontogenic myxoma cases were seen over the 21 years 
period, 22 retrospectively in the period 1982 – 1998 and 11 prospec-
tively in the period 1999 - 2002. Considering that the population of Tan-
zania is 34 million people (August 2002 national census), an incidence 
of 0.07 per million can be calculated based on the prospective data only.  
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 Table 1: Distribution of odontogenic myxoma according to age and gen-
der (N = 33) 
 
Sex Age range in years 
Male Female 
Total 
0 – 9 1 1 2 
10 –19 2 5 7 
20 – 29 4 9 13 
30 –39 3 5 8 
40 – 49 1 1 2 
> 50 1 0 1 
 12 21 33 
 
The distribution of odontogenic myxomas by age and gender is shown in 
Table 1.  
The age range was from 3 months to 64 years with a mean of 26.1 
years. The majority of the odontogenic myxomas occurred in patients 
between 10 and 39 years old.  The location of the lesions is shown in 
Table 2.  
Eight myxomas (25%) were located in the maxilla and 24 (75%) in the 
mandible. The posterior mandible was the most common location. In five 
patients the tumour occupied both the anterior and posterior parts of the 
mandible. Table 3 shows the different symptoms of 21 patients, from 
whom complete data were available. Six patients (28.5%) presented with 
varying degrees of pain. Paraesthesia of the mandibular nerve was pre-
sent in two patients. The radiographic appearance is shown in Table 4. 
 
Table 2: Distribution of odontogenic myxoma according to location. In 
one of the patients the location of the lesion was not specified. 
 
Maxilla Mandible Total
Anterior 
Incisor- 
canine 
Posterior 
Premolar-
molar 
Anterior 
Incisor-
canine 
Posterior 
Premolar-
molar 
Anterior/ 
Posterior 
 
3 5 4 15 5 32 
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 Table 3: Distribution according to presenting symptoms (N=21). Some 
patients presented with a combination of symptoms. 
 
Clinical presentation Mandible Maxilla Total
Pain 4 2 6 
Paraesthesia 2 0 2 
Ulceration 2 1 3 
Perforation of cortex and invasion of soft tis-
sues 
6 1 7 
Tooth mobility 5 0 5 
 
Sixteen out of 21 (76%) presented with a multilocular lesion while four 
(19%) were unilocular and one had a mixed appearance. Root resorp-
tion was seen in 10 out of 21 cases. 
Histology findings revealed a predominance of stellate and spindle cells 
surrounded by mucoid material (Fig. 1).  
 
 
 
 
 
 
 
Fig.1: Odontogenic myxoma sho-
wing spindle and stellate cells in a 
mucoid background (H&E 200x). 
 
 
Table 4: Distribution according to radiographic presentation (N=21). 
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Radiographic presentation Mandible Maxilla Total 
Unilocular 2 2 4 
Multilocular 11 5 16 
Mixed radiolucent-radiopaque 0 1 1 
Root resorption 10 1 11 
 Discussion 
 
The epidemiological, clinical, histopathological and radiological data pre-
sented are unique because comparable studies with the same number of 
patients are not available. The Tanzanian situation is probably different in 
that many of the tumours grow to considerable size before the patients 
seek treatment (Fig. 2). The main limitation of this study was the absence 
of files, tissue specimens and radiographs of 12 out of the 33 patients. 
However, for these patients it was possible to gather some pertinent data 
and the histopathological diagnosis.  
Despite the fact that Muhimbili University has the only department of oral 
maxillofacial surgery in the country, the incidence of 0.07 per million as 
was found in this study, should be 
considered to be the lowest figure 
possible because there are 
probably patients with OM who 
did not present to the health care 
providers.  
Fig. 2: A male patiënt with a
large odontogenic myxoma of
the mandible. 
The majority of the patients with 
OM were between the second 
and fourth decades of life with a 
peak in the third decade (Table 
1). This is in keeping with 
available information from other 
studies which indicates that 
odontogenic myxoma is most 
commonly seen in patients who 
are above the age of ten and 
below forty years.25,33 The 
youngest patient in this study was 
a 3 months old baby and the 
oldest was 64 years old. In 
general OM is rare in children 
below the age of ten and in adults 
above the age of 50.14,17,20,26,36 
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 In this study the mean period of time that the tumour was noted before 
presenting at the hospital was 3.4 years with a range of 6 months to 11 
years. Problems inherent to the country’s cumbersome health referral 
system, ignorance and, to a certain extent, poverty were the main rea-
sons for the patients’ delay to report to hospital. It is also quite a com-
mon attitude for Tanzanian patients to report late to hospital when they 
have conditions that otherwise do not seem to pose immediate danger to 
life.32 
It is apparent from this study that there was a marked gender bias with a 
male:female ratio of approximately 1:2. This is in agreement with several 
other studies from the African continent and elsewhere that also showed 
gender bias with male:female ratios ranging from 1:1.5 to 
1:4,1,3,12,15,17,25,27,30,33,36 however, others did not observe gender predilec-
tion.6,18,29,37,38  
Most of the lesions in this study occurred in the mandible as compared 
to the maxilla (2.5:1). This concurs with findings from others,3,27,33,37 al-
though some reports mentioned an equal frequency on the mandible 
and maxilla.2,4,17 In both jaws the posterior region was most often af-
fected (Table 2). 
OM is commonly described as a slow growing tumour and generally 
symptomless. However, in the present study it was quite apparent that 
as it advances in size OM may present with disturbing symptoms. Bony 
perforation, with subsequent invasion into the soft tissues was observed 
in seven patients. Pain, paraesthesia, mobility of teeth and ulceration 
were among the other complaints that patients presented with.  Two pa-
tients, who described their pain as fairly severe, belonged to the group 
with soft tissue invasion. The other four who complained of mild to 
moderate pain had intrabony lesions.  Pain, mobility of teeth or paraes-
thesia caused by OM have also been reported by other authors.9,16,34 
Patients with posteriorly located tumours presented late with bigger le-
sions than those with anteriorly located tumours. This is probably due to 
more visible disfigurement and disturbance of bite function when the le-
sions are located in the anterior area.  
Rapidly growing odontogenic myxomas have been reported in the 
literature10,15 but in the present study only the tumour in the 3 months old 
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 baby appeared to grow rapidly. In general, the impression exists that the 
duration of symptoms was in accordance with the size of the tumour and 
magnitude of the symptoms.  
Radiologically OM may appear as a unilocular or multilocular radiolu-
cency with either honeycomb, or soap-bubble pattern with cortical ex-
pansion and tooth displacement.15,17 Approximately half of the cases 
showed root resorption, which is a relatively high frequency compared to 
that reported from other studies.1,16 The radiolucency may have clearly 
defined borders or poorly defined diffuse borders.3,15,26 The radiographs 
of 16 patients showed radiolucent lesions with interlaced bone trabecu-
lae resulting in a multilocular soap-bubble or honeycomb appearance 
(Fig. 3).  
 
Fig.3: Radiograph of an odontogenic myxoma of the mandible showing 
a honeycomb multilocularity. 
 
Four lesions, two maxillary and two mandibular had a unilocular ap-
pearance. This fact points to a potential difficulty when trying to arrive at 
a proper diagnosis. A number of lesions should be included in the dif-
ferential diagnoses including ameloblastoma, intraosseous haeman-
gioma, aneurysmal bone cyst, central giant cell granuloma, mestastatic 
tumour and, in cases of unilocular lesions, simple cysts.29 A biopsy is, 
 68
 therefore, necessary to ascertain an accurate diagnosis. All the maxillary 
lesions occupied one side only (left or right). This concurs with current 
knowledge that odontogenic myxoma rarely crosses the midline. One 
patient presented with two different lesions in the mandible. 
The specimens in this study appeared macroscopically as infiltrative 
mass of mucoid or slimy material. Apparently its clinical and radiological 
limits may not histologically represent the true limits of the tumour. All 
tumours in this series were composed of loosely arranged, spindle 
shaped and stellate cells many of which had long fibrillar processes that 
tended to intermesh. The intercellular background was mucoid (Fig 1). 
Atypical nuclei were often encountered, but cellular pleomorphism, 
prominent nucleoli and mitotic 
figures were not seen. Most of 
odontogenic myxomas in this se-
ries contained little collagen, but in 
few cases areas with moderate 
amount of collagen were observed 
(Fig 4).  
In addition to these findings tu-
mours were usually interspersed 
with a variable number of tiny ca-
pillaries as shown in Fig. 1 and 
Fig. 4. Fig. 4: An odontogenic myxo-
ma with moderate amount of
collagen and a number of blood
capillaries (H&E 200x) 
Despite the fact that odontogenic 
myxoma shows aggressive local 
growth it is believed that it never 
undergoes malignant transforma-
tion or gives rise to metastasis.6  
In the present series all cases were reported to be benign. The recom-
mended treatment of choice for OM is radical surgery31 or conservative 
excision depending on tumour size.4,17,25 All the cases in this series were 
treated by surgery except for two patients who absconded and one who 
deferred operation to a later date. Radical resection including a margin 
of 1.5 - 2 cm healthy bone was the mode of treatment for all cases at our 
centre. In smaller tumours this implied a marginal resection leaving the 
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 contour of the jaw intact, while in bigger tumours a segmental resection 
or a partial maxillectomy was done. None of the treated patients pre-
sented themselves for follow-up, which makes it impossible to comment 
on the recurrence tendency. Under the Tanzanian circumstances, it is 
not always possible to conduct long term follow-up after treatment on 
routine basis. Non-availability of specialist services, reachable by the 
majority of the population, and lack of awareness by the general popula-
tion are the main reasons. It is, therefore, important that the initial treat-
ment should be appropriate. When a small tumour would be detected, 
the functional and aesthetic result will be less incapacitating even after 
such radical surgery. Consequently, considering the Tanzanian circum-
stances, radical surgery seems the best option to prevent recurrences 
as much as possible. When recurrence might occur patients will proba-
bly present late again and will consequently be hard to treat. 
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 Abstract 
 
Functional and aesthetic results and the personal satisfaction of Tanza-
nian patients, who underwent either a partial or total mandibulectomy 
due to ameloblastoma without reconstruction, were evaluated making 
use of a Quality of life (QOL) questionnaire.  
Patients with ameloblastomas of the mandible, who were treated during 
the period 2000-2002, participated in the study. Nine patients were 
treated by total mandibulectomy and 16 had a partial, continuity resec-
tion (partial mandibulectomy). 
The affected part of the mandible was resected with a margin of be-
tween 1 and 2 cm. of healthy bone. The soft tissues, including 
periosteum, muscles and skin were preserved.  
After a minimum period of one year for 21 patients the physical func-
tional status and personal satisfaction were assessed. Level of opening 
of the mouth and deviation from the midline were also recorded.  
Only five patients complained of mild pain. The postoperative problems 
were mostly associated with eating of solid foods, appearance and 
speech. All patients treated by total mandibulectomy had moderately se-
vere problems with eating of solid foods and were dissatisfied with ap-
pearance. Of the partial mandibulectomy group 12 patients had 
moderate and two had severe problems with eating of solid foods. 
The relatively small tumours resulted in much better QOL. Public aware-
ness programmes to avoid late referral and treatment is the most effec-
tive way to diminish the number of patients who after treatment suffer 
poor quality of life.  
Key words: Quality of life, ameloblastoma, total and partial mandibulec-
tomy 
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 Introduction 
 
Odontogenic tumours form a considerable portion of all tumours found in 
the oral and maxillofacial area, comprising between 2.5% and 15%.1,2 
Ameloblastoma is the most frequently occurring odontogenic tumour in 
Africa and Asia.2-8 Generally most of the odontogenic tumours are lo-
cated in the mandible as compared to the maxilla.2-4,6,8,9 Over 80% of 
ameloblastomas are located in the mandible.5,6,8 Surgery is the recom-
mended treatment of most odontogenic tumours including ameloblas-
tomas.10,11 The location and extension of the tumour determines the ex-
tent of surgery. The aggressive (locally infiltrative) tumours like 
ameloblastomas are treated by radical surgery that includes excision of 
the tumour with a 1 to 2 cm margin of healthy bone.12-15 
The mutilation of the patient probably depends much on the amount of 
tissue that is removed. Different techniques are employed to reconstruct 
lost parts of the mandible and associated structures following ablative 
surgery, including free autogenous bone grafts (rib, iliac crest, fibula) or 
titanium mesh filled with particulate bone.16-19 In Tanzania, however, 
many patients with ameloblastoma present late with rather big tumours, 
which necessitates extensive surgery, involving removal of big parts of 
the mandible or sometimes the whole mandible.8 Due to lack of re-
sources, reconstruction is usually not possible for these patients. 
There are considerable numbers of Quality of Life (QOL) studies that 
have been conducted on patients who have undergone surgery in the 
head and neck region due to cancer.20-25  
Determination of the quality of life in patients, who have undergone sur-
gery in the head and neck region, provides an objective assessment of 
their physical, psychological, and social function.24 There are, however, 
no studies available that have been conducted on patients with large 
ameloblastomas, who have undergone ablative surgery without recon-
struction.  
The aim of the present study was, therefore, to evaluate the functional 
and aesthetic results and the personal satisfaction of Tanzanian pa-
tients, who underwent either a partial or total mandibulectomy due to 
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 ameloblastoma without reconstruction, making use of a Quality of life 
(QOL) questionnaire.  
 
Material and methods 
 
Twenty-five patients with ameloblastomas of the mandible, who were 
treated during the period, 2000 to 2002, were included in this study. 
These patients were selected from a total of 42 patients with 
ameloblastomas who were seen during the same period because they 
were available for follow-up. The patients were aged 18 to 55 years 
(mean 32.2 years). There were 12 males and 13 females. Ten of the pa-
tients were small scale traders, eleven were peasants and four were 
employees of public or private sector. Nine patients were treated by 
complete mandibulectomy and sixteen had a partial, continuity resection 
(partial mandibulectomy) done at different levels. The surgical technique 
included resection of the affected part of the mandible with a margin of 
between 1 and 2 cm of healthy bone. The soft tissues, including 
periosteum, muscles and skin were preserved as much as possible de-
pending on their involvement. In patients who had complete man-
dibulectomy or in cases where the resected part included the symphysis, 
the muscles that attach at the middle of the posterior surface of the 
symphysis i.e. the genioglossus, geniohyoid and the anterior belly of di-
gastric muscles, after being detached, were sutured together in the mid-
line. The intra-oral wounds were then first carefully closed by interrupted 
or mattress sutures to prevent saliva getting into the wound.  
Patients with partial continuity resections were put on intermaxillary fixa-
tion (IMF) for 2 to 3 weeks, using the non-resected part of the mandible. 
This prevented an upward and medial shift of the non-resected mandi-
ble, which is commonly seen, especially in cases where the resection 
includes part of the symphysis. After 2 to 3 weeks the IMF was usually 
removed and patients were advised to carry out exercises to close and 
open the mouth straight as much as possible. The first week the exer-
cises were done under supervision of a junior staff member at the de-
partment of oral and maxillofacial surgery on alternate days. The patient 
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 was then instructed to continue on his/her own at home by opening the 
mouth straight while looking in a mirror.  
Patients who had a total mandibulectomy were, as of the first postopera-
tive day, instructed on how to close the mouth and keep the tongue in 
the mouth and to control the drooling of saliva. These exercises were 
continued immediately after they were ambulant.  
The patients were assessed after a maximum period of at least one year 
postoperatively.  
Using a structured questionnaire, patients were interviewed regarding 
their physical incapacitation, social and occupational life after treatment 
and their perception of their facial disfigurement. The questionnaire fol-
lowed the format of the EORTC Head and Neck Cancer Quality of Life 
Questionnaire (QLQ-C30)26,27 whereby one had to answer questions 
following a four point rating scale giving the patient the possibility to 
respond either Not at all, A little, Quite a bit or Very much. The total in 
each category were added and divided by the number of patients in that 
group (Table 1). This weighed value was used to compare between the 
group treated by complete and the one treated by partial mandibulec-
tomy. The following parameters were also recorded: level of opening of 
the mouth and deviation from the midline in millimetres. With the patient 
seated upright on a straight chair looking straight forward, the distance 
from the incisal margin of the upper central incisors to the mucosa of the 
lower jaw, in the area where the alveolar ridge was previously located 
was measured using a calliper. Using a ruler, another measurement was 
taken horizontally from the midline, between the maxillary central inci-
sors to the midline of the lip of the lower jaw or to the midline between 
the lower central incisors in cases where these teeth were present. This 
was recorded as a measure of deviation.  
 
Results 
 
There were nine patients with total mandibulectomy, whereas 16 pa-
tients had partial continuity resection of different dimensions (Table 1). 
Subjective responses from the questionnaire revealed that only four 
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 patients complained of mild pain, whereas the other 21 had no pain at 
all.  
 
Table 1: Distribution of responses from the QOL questionnaire 1 year 
after ablation. Weighed values from responses to questionnaire 
 
Problems with Total Mandibulectomy (n = 9) Partial Mandibulectomy (n = 16) Difference 
Pain n Mean value of scores n Mean value of scores  
1 
2 
3 
4 
6 
2 
1 
0 
 
 
1.3 
12 
3 
1 
0 
 
 
1.3 
 
 
0 
Drooling      
1 
2 
3 
4 
9 
0 
0 
0 
 
 
1.0 
16 
0 
0 
0 
 
 
1.0 
 
 
0 
Eating liquids      
1 
2 
3 
4 
9 
0 
0 
0 
 
 
1.0 
16 
0 
0 
0 
 
 
1.0 
 
 
0 
Eating solids      
1 
2 
3 
4 
0 
0 
9 
0 
 
 
3.0 
0 
2 
12 
2 
 
 
3.0 
 
 
0 
Speech      
1 
2 
3 
4 
0 
2 
6 
1 
 
 
2.9 
5 
6 
1 
4 
 
 
2.3 
 
 
0.6 
Appearance      
1 
2 
3 
4 
0 
0 
0 
9 
 
 
4.0 
3 
8 
0 
5 
 
 
2.4 
 
 
1.6 
Family relation      
1 
2 
3 
4 
9 
0 
0 
0 
 
 
1.0 
16 
0 
0 
0 
 
 
1.0 
 
 
0 
Social/work relat.      
1 
2 
3 
4 
5 
3 
1 
0 
 
 
1.5 
11 
3 
1 
1 
 
 
1.5 
 
 
0 
Stress/anxiety      
1 
2 
3 
4 
4 
2 
3 
0 
 
 
1.9 
9 
6 
0 
1 
 
 
1.5 
 
 
0.4 
Financial problems      
1 
2 
3 
4 
2 
3 
3 
1 
 
 
2.3 
4 
6 
4 
2 
 
 
2.3 
 
 
0 
Legend: 1 = Not at all, 2 = A little bit, 3 = Quite a bit, 4 = Very much 
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 None of the patients had any problem with drooling of saliva or taking 
liquid foods. The general trend when the scores are added shows that 
postoperative problems were mostly associated with eating of solid 
foods, appearance and speech. 
All patients (9) treated by total mandibulectomy had moderately severe 
problems when eating solid foods. Of the patients who were treated by 
partial mandibulectomy, two had mild problems with eating solid foods, 
12 had moderately severe and the other two experienced very severe 
problems.  
All patients who were treated by total mandibulectomy reported to be 
very dissatisfied with  their appearance. Three of the patients with partial 
mandibulectomy had no complaint regarding their appearance, eight 
complained of little dissatisfaction and five were very much dissatisfied. 
Three out of nine patients treated by total mandibulectomy and another 
three out of 16 patients treated by partial mandibulectomy experienced 
minor problems associated with social and work relations. None of the 
patients reported problems with their family relations. One patient with 
partial mandibulectomy suffered severe problems regarding social and 
work relations. In both the complete and partial mandibulectomy group 
only eleven patients suffered mild to moderate stress and anxiety and 
one suffered severe anxiety. Only six patients reported not to have suf-
fered any financial hardships due to the treatment they had undergone. 
In the complete mandibulectomy group three patients suffered little fi-
nancial difficulties while another three suffered moderate and one suf-
fered severe difficulties. From the partial mandibulectomy group, ten pa-
tients suffered mild or moderate financial difficulties and two reported 
having suffered severe difficulties. Four patients had no problems at all. 
Altogether all patients except one had a maximum mouth opening of at 
least 30 mm (Table 2).  
Deviation was not observed in patients with complete mandibulectomy 
or those with symmetrical bilateral resection of the mandible. 
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 Table 2: Mouth opening and deviation. 
 
Partial Mandibulectomy (n = 16) Total Mandibulectomy (n = 9)
Mouth opening Deviation Opening 
n mm n mm n mm 
8 
3 
3 
2 
30 
32 
34 
35 
2 
1 
4 
5 
3 
0 
1 
0 – 2 
3 – 4 
5 – 6 
7 – 8 
9 – 10 
11 – 12 
≥ 13 
1 
2 
3 
3 
27 
30 
34 
35 
Weighed means of mouth opening for the two groups: Partial mandibu-
lectomy 31.8 Total mandibulectomy 32.7. 
 
Discussion 
 
To the best of our knowledge this is the first study dealing with QOL of 
patients who have been treated for mandibular ameloblastomas in a de-
veloping country. In developed countries only studies dealing with ma-
lignant tumours use quality of life questionnaires. Segmental man-
dibulectomies have been associated with poor health–related QOL, par-
ticularly before composite free tissue transfers to reconstruct the defects 
were used.28 
All the patients included in this study were interviewed after a minimum 
of one-year follow-up. Based on the data presented it appears that, over 
time the patients were able, to a certain extent, to adapt to the situation. 
However, judged from the physical, psychological and social status, this 
group of patient’s quality of life, in one way or another, had been af-
fected in a negative way. Patients with ameloblastomas in Tanzania 
usually present with big tumours, sometimes too big to allow saving any 
part of the mandible8 (Fig. 1a). 
The nature of the treatment of these patients was determined according 
to the size and extent of the tumour. The bigger the tumour, the larger 
the resection. Where it was impossible to leave behind any healthy part 
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 of the mandible, a total mandibulectomy, that entailed bilateral disarticu-
lation, was decided upon (Fig. 1b). From the results presented it is clear 
that patients who had smaller resections also had less problems com-
pared to those who had larger resections or total removal of the mandi-
bles (Table 1) 
 
 
 
 
Fig. 1a: Preoperative situation of 
a 26 years old patient with a large 
ameloblastoma occupying almost 
the whole mandible. 
Fig. 1b: Six months post opera-
tive situation after complete 
mandibulectomy showing some 
disfigurement of the lower face. 
 
The operative procedure in all patients included preservation of the cen-
tral muscle attachments where possible. In the cases where the muscles 
had to be detached from the mandible, the procedure of suturing them 
together at the base of the tongue and then to the skin was adopted. 
This probably contributed to a large extent to the patient’s ability to con-
trol the tongue and, therefore, to swallow without problems which had a 
positive effect to their QOL.  
The beginning of exercises to open the mouth immediately after the 
operation is a good measure to make the patient adapt early. It should 
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 be noted that all these patients could not control jaw movements and 
saliva during the first few post-operative days, because of oedema or 
because they feared pain. Within the first one month, however, most of 
the patients could control saliva (no drooling) and by the second month 
the majority in the partial mandibulectomy group had been able to regain 
normal speech. Regarding speech, however, the group with complete 
mandibulectomy had moderate to severe problems even one year post-
operatively. In fact, this is one of the major handicaps that they have to 
live with throughout their lives. This underscores the importance of early 
reporting and treatment when the sizes of the tumours are still relatively 
small. The patients who had partial mandibulectomy but suffered speech 
problems were those who had tumours located at the symphysis of the 
mandible whereby resection had led to detachment of the muscles. With 
partial mandibulectomy, therefore, location rather than size was the ma-
jor determinant of the QOL. 
Not being able to eat solid foods was a major handicap to both groups of 
patients. From the results, cumulative scores show that this was the 
most severe problem in both partial and total mandibulectomy groups. 
The loss of the masticatory ability affects their QOL in a negative way. 
The scores, however, are better in patients who had partial man-
dibulectomy compared to those who had a complete mandibulectomy. 
Part of the apparent adaptability should be attributed to the fact that 
most of these patients were relatively young Appearance dissatisfaction 
was reported as the second most severe problem and it affected more 
often patients who were treated with total mandibulectomy or partial 
mandibulectomy with tumours that included the symphysis. The majority 
of patients with partial mandibulectomy showed only little dissatisfaction 
and two had completely adapted. One patient from this group, however, 
was very dissatisfied. The degree of dissatisfaction was directly related 
to the extent of the surgery.  
The World Health Organisation (WHO) in 1948 defined health as not 
only being free of disease or pain, but also rather “a state of complete 
physical, mental, and social well-being “. For our group of patients, 
therefore, despite the efforts to make them free of tumour, their life still 
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 demands improvement. Although the disease was cured, physically and 
psychologically they were affected.  
Little can be done for the patients who had undergone total man-
dibulectomy except to improve aesthetics. Their QOL is generally poor 
(Fig. 1b).  
Current reconstruction methods probably fail to improve speech and 
eating of food because muscle attachment and nerves have been 
severed and cannot be restored. The best option should be replacement 
of the lost mandible by a composite graft (most likely the fibula). This 
would probably improve aesthetics. Functional rehabilitation however, 
would require an implant-supported prosthesis, which in Tanzanian 
circumstances is unaffordable.  Because of this all our efforts should be 
directed towards preventing total mandibulectomies. This implies, that 
the public and health care providers ought to be aware that most benign 
tumours of the jaws can be cured with a reasonable post operative QOL, 
provided the tumours are relatively small. The patients undergoing par-
tial mandibulectomy seem to have a better QOL than patients with a to-
tal mandibulectomy (Table 1). Yet, even in this group particularly func-
tions like eating, speech and aesthetics appear to have considerable im-
pact on their well being (Fig. 2a and 2b)  
The results of this study show that a vigorous public awareness pro-
gramme to avoid late referral for jaw tumours would probably be the 
most effective way to diminish the number of patients with severe facial 
disfigurement. 
This should be done through education to the public and health workers 
on the importance of early identification and referral. Continuing educa-
tion to dental personnel who are the first to see the majority of these pa-
tients would be one of the best means of achieving this.  The study also 
shows that surgery for the removal of relatively small tumours result in 
much better QOL. The QOL of these patients can probably be improved 
further by immediate reconstruction. There is a need for an affordable 
yet, reliable method to do these reconstructions especially in the less de-
veloped countries. 
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Fig. 2a: Preoperative facial 
appearance of an 18 years 
old woman with left man-
dibular ameloblastoma. 
 Fig. 2b: Six months post opera-
tively, showing mouth opening 
with 13 mm shift of the mandible 
to the left. The mandibulectomy 
crossed the midline. 
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 Abstract 
 
This study presents the results on 11 patients suffering from ameloblas-
toma who had ablative surgery followed by immediate reconstruction of 
the mandible in one single operation. In six of the patients the tumour 
was removed from the cortical scaffold, which was then irradiated with 
50Gy. Perforations were made in the scaffold, placed back to fit the de-
fect and was held in place by custome made titanium plates, fixed on 
both ends with screws. Particulate bone chips, taken from either the an-
terior or posterior iliac crest, were mixed with autogenous platelet rich 
plasma (PRP) and Tissue Col®  in order to promote early vascularization. 
In five of the patients the cortical scaffold was not used but rather a 
mixture of bone and PRP was packed into the defect under the titanium 
plates. 
Four patients in the scaffold group had complications varying from frac-
ture of the scaffolds to infection. None from the group reconstructed 
without scaffolds suffered any complications. A quality of life assessment 
(QOL) of the 7 successful cases showed that these patients were satis-
fied and had a good QOL. 
These results imply that this immediate means of reconstruction is feasi-
ble and thus, offers a considerable advantage to the patients.  
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 Introduction 
 
Reconstruction of mandibles after ablative surgery for benign or malig-
nant tumours still poses a challenge for the profession. Microvascular 
anastomosed grafts are currently the gold standard for reconstruction of 
lost parts of the jaws in the developed world.2,22,30,34,35 In developing 
countries, however, this technique can usually not be used because of 
economic reasons and shortage of manpower.  
In most African countries benign, but aggressive tumours such as 
ameloblastoma or myxoma are more frequently encountered as com-
pared to malignancies.26 These benign tumours are usually rather big 
when the patient present to hospital and most often require segmental 
resection.4,18,19,26 The resulting defects are thus, rather big as well, but 
usually would not require composite flaps because the soft tissues are 
not resected along with the mandible. These defects would best be 
treated with bone grafts, preferably immediately following the resection. 
Most patients suffering from odontogenic tumours are also relatively 
young as compared to the group of patients suffering from squamous 
cell carcinomas.1,13,21,26 The need for adequate primary reconstruction is, 
therefore, even more pressing since most of the patients are in the midst 
of their active life (Fig. 1a). A quality of life (QOL) study revealed con-
siderable invalidation in this patient group, which calls for an adequate, 
yet affordable means of reconstruction for these patients.27  
Immediate reconstruction with free, block bone grafts would be possible 
in many cases but the risk of failure because of infection is rather high. 
Tumour resection requires an intra and extra oral approach with subse-
quently inevitable contamination of the non-vascularised graft by oral 
flora. Bone healing and incorporation of the graft is, therefore, often im-
paired. Most surgeons would, therefore, be inclined to reconstruct the 
mandible in a later stage and primarily maintain the three-dimensional 
relationship using reconstruction plates.9,13,24,32 
In the Tanzanian circumstances the two-staged treatment would not be 
applicable for several reasons. First, patients could not afford a second 
operation because of economic reasons. Second, because of the long 
distances, follow up of the reconstruction would be near to impossible. 
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 For developing countries, including Tanzania, it is recommendable to 
develop a method of reconstruction, which could be carried out immedi-
ately after the resection at the same operation, whilst at the same time 
the risk of failure should be as little as possible. Different techniques of 
reconstruction of the mandible have been performed with various levels 
of success.3,10,13,23,25,31 The use of particulate cancellous bone and mar-
row (PCBM) and allogenic scaffolds has for a long time been applied to 
reconstruct mandibles in oncology patients with good results.8,14,25,37  
Recent studies have shown that there may be a good alternative to the 
relatively complicated, expensive and time-consuming microsurgical re-
pairs.6,7,16 The use of autogenous particulate bone and autologous 
platelet rich plasma (PRP) in mandibular reconstructive surgery was 
proposed by Tayapongsak et al..28 Whitman et al.,35 Whitman & Berry,36 
Marx et al.,14 Thorn et al.29 and Merkx et al.16 have presented excellent 
results on secondary reconstruction making use of autogenous particu-
late bone grafts and autologous PRP. This clinical research was sup-
ported by animal experiments of Fennis et al..6,7 The addition of custom-
made 2.3 mm titanium plates to rigidly fix the graft gave an extra dimen-
sion to this mode of reconstruction.16 
It is the aim of this study to present results on a group of selective pa-
tients suffering from benign, but aggressive odontogenic tumours, who 
were reconstructed in one operative procedure after ablative surgery, 
according to the above-mentioned principles, in Tanzania. 
 
Material and methods 
 
Eleven patients suffering from ameloblastoma were selected for this re-
construction method. The selection criteria included a tumour, which oc-
cupied part of the mandible but would leave two adequate stumps after 
resection. These stumps would allow fixation of the plates with at the 
least two monocortical screws on each side. Patients had to sign an in-
formed consent before the planned reconstruction, which in Tanzania 
implies a cost factor among other considerations. 
One day prior to the operation 450 cc of blood was drawn from the pa-
tient at the blood bank. This blood was prepared to get a standard 
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 platelet concentrate.20,29 On the day of the operation a further centrifuga-
tion was done to get 10-12 cc. with a concentration of between 1 - 2 x 
106 platelets per mm3. 
The first six patients had a segmental resection to remove an 
ameloblastoma. The oral layer was first closed with tight mattress su-
tures after which the wound was washed out with sterile saline. The re-
sected specimens of the mandible were treated by removal of the tu-
mour ex corpora. This implied complete removal of all the marrow bone 
and trimming of the cortical rim if the tumour had perforated the cortex. 
These cortical scaffolds were then irradiated with 50 Gy and immediately 
put back and fixed with two custom preshaped 2.3 mm titanium plates 
(SMART® plates, Martin Company) that, if feasible, bridged the whole 
gap (Fig. 1b). In the first three cases, however, plates long enough to 
bridge the gaps, were not available. The cortical crib was filled with a 
mixture of spongious, autogenous bone particles taken from the anterior 
iliac crest and autogenous PRP, which was activated by CaCl2-throm-
bine mixture (Tissue col®) to initiate the formation of fibrin.6,16 The skin 
and subcutaneous tissue were closed in a routine fashion. Intermaxillary 
fixation with stainless steel wires was applied in all cases, for a period of 
4 weeks.  
In the next five patients, because of the experience gained with the pre-
vious 6 patients, the treatment protocol was changed by not using the 
autogenous radiated cortical scaffolds anymore. After the intraoral tis-
sues were sutured, the gap was filled with a mixture of autogenous bone 
particles taken from the anterior or posterior iliac crest and autogenous 
PRP, which was activated by CaCl2-thrombine mixture. The bone parti-
cles after activation of PRP were packed against the plates. The platelet 
gel kept the particles in place. 
All patients were put on Ampicillin 500 mg i.v. 8 hourly 24 hours before 
the operation, in combination with Metronidazole 400 mg i.v. 8 hourly for 
five days postoperatively. The decision to stop or continue with the anti-
biotics beyond five days was made mainly depending on the condition of 
local wound healing and general condition of the patient.  
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 Postoperative radiographs were taken immediate post operatively and at 
4, 6 and 12 months if feasible, to assess the bone condition and to 
monitor bone formation.  
To compare the QOL of these 7 successfully reconstructed patients with 
the patients whose mandibles were not reconstructed after ablative sur-
gery, the same questionnaires (EORT QLQ-C30) were filled out by the 
patients, 4 to12 months after reconstruction.27 The patient was required 
to answer questions following a four point rating scale giving the patient 
the possibility to respond either Not at all, A little, Quite a bit or Very 
much. These were scored by numbers from 1 to 4, so that, those who 
had higher scores were most dissatisfied. 
 
  
Fig. 1a: A young lady with a huge 
ameloblastoma of the mandible 
extending from right to left body 
and ramus. 
Fig. 1c: Facial appearance 4 
months postoperatively. 
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 Fig. 1b: Radiograph 4 months after ablative surgery and simultaneous 
reconstruction of the mandible. 
 
Results 
 
A total of 11 patients, six males and five females, were treated as 
described before, six with radiated autogenous cortical scaffolds and five 
without (Table 1). The age range was 17- 47 years (mean 27 years). 
Regarding the six patients whose mandibles were reconstructed using 
cortical scaffolds, two (case 2 and 5) suffered fractures of the cortical 
scaffolds. Another patient  (case 4) had breakdown of the oral mucosa 
followed by infection and later loss of the graft. In this patient the metal 
plate became loose at one end, which, due to inadequate, length was 
fixed by only two screws at both ends. The other three (cases 1, 3 and 
6) had good bone healing, filling and bridging the whole osseous defect. 
Case 3, however, had a recurrent ameloblastoma. At the second opera-
tion to excise the recurrent tumour, it appeared that there was good 
bone healing. As for the five patients who were reconstructed without 
cortical scaffolds, but with two plates long enough to bridge the osseous 
defect, there were no complications immediate postoperatively and after 
a follow-up of 4-24 months (Fig. 1b).  
From the answers of the QOL questionnaire it appears that the main im-
provement was gained in “appearance” resulting in improvement of so-
cial and work relations and as a consequence financial problems, as 
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 compared to the results in non-reconstructed patients27 (Fig. 1c). Dimi-
nished pain contributed also to improvement of the QOL. (Table 2).  
 
Discussion 
 
Primary reconstruction of mandibular defects after resection of benign, 
aggressive lesions in a developing country would probably be the most 
appropriate way to improve quality of life of the patients. The department 
of Oral Surgery and Oral Pathology of the Muhimbili National Hospital in 
Dar es Salaam, is the only centre with an oral and maxillofacial surgery 
service in Tanzania. All patients with tumours that require attention of 
oral and maxillofacial surgeons from all over the country are referred to 
this centre for treatment. Most of the patients, however, present with big 
tumours that necessitate removal of large portions of the mandible, 
which makes reconstruction difficult. The situation is made worse by the 
fact that the treatment of ameloblastoma requires resection of the tu-
mour with part of healthy bone to avoid the possibility of recurrence.5,12,17 
Therefore, this group of patients was selected on the basis of the size of 
the tumours, patient’s informed consent and suitability for reconstruction 
by this method.  
The idea for using irradiated cortical scaffolds has derived from the stu-
dies of Jisander et al..9 who used irradiated cortical scaffolds to secon-
darily reconstruct mandibles after ablative surgery for oral cancers. 
Our results of reconstruction with radiated cortical scaffolds were less fa-
vourable in three patients, two of whom (case 2 and case 5) had fracture 
of the scaffolds and one (case 4) had breakdown of the wound during 
the first postoperative week followed by infection. In the two patients 
who had fractured scaffolds this most likely occurred because the plates 
did not bridge the whole defect. On top of that the radiated scaffolds 
probably acted like foreign bodies as was shown in the study of Fennis 
et al..7 They found in a study on goats, using radiated autogenous corti-
cal bone that the scaffold was not satisfactory because it appeared to 
hamper healing of the autogenous bone graft inside the scaffold. The re-
sults of that study made us change the reconstruction technique.  
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 Table 1: Conditions of reconstruction patients. 
No. Gender Age  Preoperative  Technique  4-6 months post op-
erative  
1 year post operative  Complications 
1 F 36 Multilocular lesion. Left 
body of mandible.  
Three plates. One bridging 
the whole gap. 
bone formation visible on 
radiograph.  
Patient doing well. Bone 
consolidation 
None.  
2 M 23 Multilocular lesion. Left 
body of mandible.  
Two plates one from poste-
rior and another from ante-
rior. None bridging whole 
gap.  
Fracture of scaffold at the 
middle. Loss of particulate 
bone chips. 
Patient’s condition deterio-
rated. Died of pulmonary 
tuberculosis 11 months 
post operative. 
Loss of particulate bone chips. Plate 
traumatizing oral tissues. 
3 F 33 Multilocular lesion on left 
body and angle of man-
dible.  
Single plate bridging the 
whole gap. 
Bone formation visible on 
radiograph. Signs of re-
currence in the newly 
formed bone.  
Radiological features of 
recurrence, some pain from 
the operation site. 
Second operation. Partial man-
dibulectomy. On operation good 
bone formation and consolidation 
observed. Patient doing well. 
4 M 24 Multilocular lesion. Left 
body of mandible. 
Single plate bridging the 
whole gap fixed by two 
screws only. 
Breakdown of the oral 
mucosa, infection and 
loss of the bone graft.  
Infection was controlled, 
patient doing well. Com-
plete bone loss. 
Plate traumatizing oral tissues. 
Second operation to remove plate. 
5 M 17 Multilocular lesion from 
the left angle, body to 
symphysis. 
Two plates one from the 
angle and the other from 
the symphysis. None 
bridging the whole gap.  
Fracture of scaffold. Loss 
of particulate bone chips. 
Plates traumatizing oral 
soft tissues. 
Plates were traumatizing soft tis-
sues. Operated to remove the 
plates. Patient doing well. 
6 F 36 Multilocular lesion on 
right body of the man-
dible.  
Single metal plate bridging 
the whole gap. 
Patient doing well. Signs 
of bone formation on ra-
diographs.  
Patient doing well. Bone 
consolidation on radio-
graphs. 
None.  
7 M 47 Multilocular lesion on the 
symphysis region.  
Two plates bridging the 
whole gap.  
Patient doing well.Signs of 
bone formation on radio-
graphs.  
Patient doing well. Bone 
consolidation on radio-
graphs 
None.  
8 M 21 Multilocular lesion on the 
left body of mandible and 
symphysis. 
Two plates bridging the 
whole gap. 
Patient doing well.Signs of 
bone formation on radio-
graphs.  
Patient doing well. Bone 
consolidation on radio-
graphs. 
None.  
9 M 17 Multilocular lesion on the 
left ramus, angle and 
symphysis of the mandi-
ble. 
Two plates bridging the 
whole gap. 
Patient doing well.Signs of 
bone formation on radio-
graphs.  
Patient doing well. Bone 
consolidation on radio-
graphs.  
None. 
10 F 17 Multilocular lesion on the 
right body of the mandi-
ble.  
Two plates bridging the 
whole gap. 
Patient doing well.Bone 
formation visible on radio-
graphs.  
-----------  None.
11 F 20 Multilocular lesion on the 
left angle, body and 
symphysis of the man-
dible.  
Two plates bridging the 
whole gap. 
Patient doing well.Bone 
formation visible on radio-
graphs.  
-----------  None.
 
 
  
 Table 2: Results of QOL from 25 ameloblastoma patients operated with-
out reconstruction25 and those who underwent immediate reconstruction. 
 
 
QOL questionaire adapted from EORTC H&N C-30. Weighed values from 
responses to questionnaire. 
Problems with Total Mandibulectomy 
(n = 9) 
Partial Mandibulectomy 
(n = 16) 
Successful Reconstruction 
(n = 7) 
Pain n Mean value of 
scores 
n Mean value of 
scores 
n 
 
Mean value of 
scores 
1 
2 
3 
4 
6 
2 
1 
0 
 
 
1.3 
12 
3 
1 
0 
 
 
1.3 
7 
0 
0 
0 
 
 
1.0 
 
Drooling       
1 
2 
3 
4 
9 
0 
0 
0 
 
 
1.0 
16 
0 
0 
0 
 
 
1.0 
7 
0 
0 
0 
 
 
1.0 
Eating liquids       
1 
3 
4 
9 
0 
0 
0 
 
 
1.0 
16 
0 
0 
0 
 
 
1.0 
7 
0 
0 
0 
 
 
1.0 
Eating solids       
1 
2 
3 
4 
0 
0 
9 
0 
 
 
3.0 
0 
2 
12 
2 
 
 
3.0 
0 
2 
3 
2 
 
 
3.0 
Speech       
1 
2 
3 
4 
0 
2 
6 
1 
 
 
2.9 
5 
6 
1 
4 
 
 
2.3 
5 
2 
0 
0 
 
 
1.3 
Appearance       
1 
2 
3 
4 
0 
0 
0 
9 
 
 
4.0 
3 
8 
0 
5 
 
 
2.4 
7 
0 
0 
0 
 
 
1.0 
Family relation       
1 
2 
3 
4 
9 
0 
0 
0 
 
 
1.0 
16 
0 
0 
0 
 
 
1.0 
7 
0 
0 
0 
 
 
1.0 
Social/work relation       
1 
2 
3 
4 
5 
3 
1 
0 
 
 
1.5 
11 
3 
1 
1 
 
 
1.5 
7 
0 
0 
0 
 
 
1.0 
Stress/anxiety       
1 
2 
3 
4 
4 
2 
3 
0 
 
 
1.9 
9 
6 
0 
1 
 
 
1.5 
6 
1 
0 
0 
 
 
1.1 
Financial problems       
1 
2 
3 
4 
2 
3 
3 
1 
 
 
2.3 
4 
6 
4 
2 
 
 
2.3 
6 
1 
0 
0 
 
 
1.1 
2 
Legend: 1 = Not at all; 2 = A little bit; 3 = Quite a bit; 4 = Very much 
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 The next five patients were treated without a scaffold but with plates that 
bridged the whole gap. Proper suturing of the intra oral soft tissues and 
the use of appropriate antibiotics are the best means of preventing infec-
tion through invasion from the oral bacterial flora. In the case of the pa-
tient who had infection, the nasal–gastric tube was erroneously removed 
postoperatively to soon (i.e. 48 hours). The patient then started feeding 
orally, which led to opening of the intra-oral wound and hence the micro-
bial invasion and ultimately loss of the graft.  
The reason why two patients ended up with reconstruction without at 
least one plate bridging the whole defect needs clarification too. After in-
troduction of the technique in Tanzania plates long enough to bridge the 
rather large defects were not available yet.  
Other authors have previously described the success and usefulness of 
growth factors with PRP in wound and bone healing.7,11,14,16,27,29,35,36 This 
has been attributed to the presence of high concentrations of autogenous 
growth factors within the PRP. The use of autologous blood reduces the 
possibility of cross infection of blood borne diseases like Hepatitis B 
(HBV) or Human immunodeficiency virus (HIV), which is important con-
sidering the Tanzanian environment because of the high prevalence of 
HIV infection.15 The PRP preparation process is easy and does not affect 
the operation time. The morbidity related to donor site in all the patients 
was negligible.  
The reason why there is a high success rate in this limited group of pa-
tients needs explanation. The platelet gel might protect the bone graft 
from invasion of microorganisms,28 whilst PRP is supposed to promote 
early revascularisation.16 The results described are very much in line with 
the results described by other authors using this principle for secondary 
reconstructions.14,16,29 
An alternative approach to primary reconstruction includes the method 
proposed by Tideman et al..31 and Samman et al...23 They use custom-
made titanium trays fabricated on a 3-D model. These trays are filled with 
compressed particulate bone grafts. They used this technique also mainly 
for the same type of lesions, i.e. benign but aggressive odontogenic tu-
mours. This method certainly produced good results but will not be feasi-
ble in the Tanzanian circumstances because of lack of resources.  
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 Although we are aware of the short follow up on the successfully treated 
patients presented, they were satisfied with the results and had good 
quality of life because of an adequate aesthetics and a functioning man-
dible (Table 2). This is a considerable improvement as compared to the 
results obtained in a group of non-reconstructed patients27 (Table 2). 
The results presented, however, need to be substantiated in a larger 
group of patients followed over a longer period of time. 
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 Summary 
 
In Chapter 1 the rationale of the study is presented. Odontogenic tu-
mours form a large part of the daily workload in Dar es Salaam, Tanzania. 
The patients treated usually present with large tumours with a long his-
tory. There are several factors that contribute to the fact that in Tanzania 
the patients present late. They include socio-economic factors but are 
also related to the structure of the health care delivery in Tanzania.  
In order to plan on manpower and education and training of oral and 
maxillofacial surgeons, it was thought to be necessary to gain an impres-
sion on the magnitude of the problems. For this reason a retrospective 
and prospective study on odontogenic tumours was deemed necessary. 
There is a major problem concerning the quality of life (QOL) of patients 
who underwent segmental resection of the mandible for benign but ag-
gressive tumours. Till 1999 no attempts were made to reconstruct these 
patients. These patients were, therefore, often severely invalidated. There 
is a need to quantify this problem as well.  
A novel technique was introduced in 1999 to reconstruct a selected group 
of patients with a special bone graft technique. It was also the purpose of 
this study to evaluate the results of this treatment and to assesd patients’ 
satisfaction using a QOL questionnaire.  
As a result of the above mentioned considerations the following research 
questions were formulated:  
• What is the relative frequency of odontogenic tumours among 
Tanzanians in relation to other tumours in the oro-facial region? 
• What is the prevalence and incidence of odontogenic tumours and 
what are the clinical and pathological characteristic features? 
• What is the incidence of odontogenic myxoma and what are the 
typical clinical, radiographic and pathological features? 
• What is the quality of life of patients who underwent ablative sur-
gery for aggressive odontogenic tumours without reconstruction? 
• Is it possible to primarily reconstruct patients undergoing ablative 
surgery due to odontogenic tumours with relatively simple means? 
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 Chapter 2. In this chapter the aim was to retrospectively document the 
pattern of occurrence of odontogenic tumours in Tanzania over fifteen 
years. The histologic types, site, age and sex distribution of odontogenic 
tumours in Tanzania from 1982 to 1997 were reviewed. Records of pa-
tients, who presented to the four referral centres in Tanzania and who 
had histologically proven oral tumours and tumour-like conditions, were 
examined.  
Odontogenic tumours comprised about 12.2% of all oral tumours and tu-
mour-like conditions. The majority of odontogenic tumours (55.3%) were 
seen in patients below 30 years of age and they more commonly affected 
the mandible than maxilla. Ameloblastoma was the most commonly seen 
odontogenic tumour (73.7%), followed by odontogenic myxoma (10.3%). 
The site, sex, and histologic distribution of ameloblastoma did not differ 
from other African studies. Over 50% of patients with ameloblastoma pre-
sented to hospital late i.e. after three or more years.  
 
Chapter 3 covers a study that aimed at determining the epidemiology and 
clinicopathological presentation of different odontogenic tumours in Tan-
zania. A prospective study on odontogenic tumours was conducted over 
four years between 1999 and 2003. All patients with odontogenic tu-
mours, who were referred from all dental clinics and other health facilities 
in the country to the only four referral centres, were included in this study. 
They were ultimately referred to the only maxillofacial treatment centre at 
Dar es Salaam where demographic data, the results of clinical examina-
tion and histopathological findings were recorded. Histopathological 
specimens were processed and examined by the Pathology department 
of the Muhimbili University College of Health Sciences, Tanzania and re-
viewed at the Oral Pathology department of the Free University Academic 
Hospital, Amsterdam, The Netherlands.  
The results showed that ameloblastoma had the highest relative fre-
quency (80.1%) and an incidence rate of 0.68 per million, followed by 
odontogenic myxoma (7.0%) with an incidence rate of 0.07 per million. 
Follow up examinations of between six months and fours years were car-
ried out and two patients were found to have recurrences of ameloblas-
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 toma. Generally patients presented late, mostly when they experienced 
already a certain degree of incapacitation. 
 
Chapter 4. A study on odontogenic myxoma, a rare tumour that occurs in 
the jaws, that has been reported to be the second commonest odonto-
genic tumour in many countries, is presented. The aim of the study was to 
describe the clinicopathological presentation of a relatively large series of 
odontogenic myxomas in Tanzania. For this reason a retrospective study 
was carried out over a 16 year period (1982-1998) and a prospective 
study over a 4 year period (1999-2002). A total of 33 cases of myxoma 
were found with a male:female ratio of 1:1.83. Most of the tumours were 
located in the mandible as compared to the maxilla and were predomi-
nantly multilocular. Pain, disaesthesia, ulceration, invasion of the soft tis-
sues and tooth mobility were among the symptoms that patients pre-
sented with although the majority had no clinical signs or symptoms.  
 
In Chapter 5 the aim was to evaluate the functional and aesthetic results 
and the personal satisfaction of the Tanzanian patients, who underwent 
either partial or total mandibulectomy due to ameloblastoma without re-
construction, using a QOL questionnaire. Patients with ameloblastomas 
of the mandible, who were treated during the period 2000-2002, partici-
pated in the study. Nine patients were treated by total mandibulectomy 
and sixteen had a partial, continuity resection (segmental mandibulec-
tomy). After a minimum period of one year, they were interviewed. It was 
found that only five patients complained of mild pain. The postoperative 
problems were mostly associated with eating of solid foods, appearance 
and speech. All patients treated by total mandibulectomy had moderately 
severe problems with eating of solid foods and were dissatisfied with ap-
pearance. Of the partial mandibulectomy group 12 patients had moderate 
and two had severe problems with eating of solid foods. 
 
In Chapter 6 the results are presented of a selected group of eleven pa-
tients who were immediately reconstructed with an autogenous, particu-
late bone graft mixed with PRP and stabilized with preshaped or straight 
2.3 mm plates (SMART®, Martin Company, Germany). From this study it 
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 can be learned that indeed primary reconstruction is possible making use 
of this relatively simple technique. QOL scores of the successfully treated 
patients attested to the success of the treatment. The means of fixation 
proved to be adequate, provided the plates bridged the whole defect. This 
model might need further improvements in the future using advanced 
bone engineering techniques but the basic principles of fixation and pri-
mary reconstruction proved to be feasible. 
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 Conclusions 
 
1. The site, sex, and histologic distribution of ameloblastoma did not 
differ much from other African studies.  
2. Despite the fact that ameloblastoma had the highest frequency, its 
incidence in this exclusively black population did not differ from 
that of European countries. This is contrary to the long held belief 
that ameloblastoma has a higher incidence in Blacks as compared 
to Caucasians. 
3. In order to improve on the treatment outcome, the need for early 
detection and referral of patients by medical personnel and den-
tists is stressed.  
4. In cases of benign but aggressive odontogenic tumours, like odon-
togenic myxoma and ameloblastoma, radical surgery with resec-
tion of the tumour with a safe margin to prevent recurrences, is 
advocated. 
5. The relatively small tumours result in much better QOL after treat-
ment. Public awareness programmes to avoid late referral and 
treatment is the most effective way to diminish the number of pa-
tients, who after treatment, have a poor quality of life.  
6. Primary reconstruction, using particulate autogenous bone grafts 
mixed with PRP and stabilised with preshaped plates, is possible. 
It turned out to be an excellent means to improve QOL in a se-
lected group of patients. 
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 Future Perspectives 
 
From the findings of this study it can be learned that there is a need for 
more centres in Tanzania where this type of tumours can be treated. 
They should be geographically located such that the population can be 
served adequately. This also implies that more oral and maxillofacial sur-
geons are needed to cope with the workload. This would largely alleviate 
the problems that currently most patients face, when they have to travel 
from the districts to the only centre that is available. It would also facilitate 
better follow-up and additional treatment when necessary. The dental de-
partments of the existing consultant hospitals in Tanzania, (KCMC, 
Bugando, and Mbeya) which are strategically situated to adequately 
cover the country should be elevated into fully equipped and well staffed 
maxillofacial centres in the nearest future. One also has to realise that 
there are other conditions that need to be attended by oral and maxillofa-
cial surgeons such as infections, trauma, malignancies, congenital 
anomalies and other lesions.   
There is an obvious need for a public awareness programme but, also, for 
additional medical and dental training and continuing education of the 
dental therapists, assistant dental officers and dental surgeons who are 
working in the districts and regions. This may be accomplished by in-
structional courses, conducted by oral and maxillofacial surgeons, di-
rected towards increasing their clinical and diagnostic competence. This 
knowledge shall enable them to detect tumours, take, appropriate 
measures and when necessary refer the patients. It will also help them to 
send across the proper message to the public. 
The quality of life study points to a fair amount of dissatisfaction among 
patients treated without reconstruction. Adequate reconstruction is possi-
ble in many cases including the technique described and techniques in-
volving microsurgery. It might be possible, in future, to concentrate com-
plicated microsurgical reconstructions in one centre. Sophisticated means 
of surgery using microsurgery, however, are time consuming and expen-
sive. This makes them not suitable for routine use in countries such as 
Tanzania where the limited funds available for health care are mostly 
spent on matters with higher priorities. 
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 Further improvements on reconstruction may involve more advanced tis-
sue engineering techniques, but they also have to be affordable for the 
Tanzanian patient.  
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 Muhtasari 
 
Umuhimu wa utafiti huu umeelezwa katika sura ya 1. Tyuma 
zinazohusiana na meno ni sehemu kubwa ya mambo 
yanayoshughulikiwa kila siku katika idara ya upasuaji wa kinywa mataya 
na uso katika skuli ya meno ya Chuo Kikuu Kishiriki Cha Sayansi ya Afya, 
Muhimbili, Dar es Salaam, nchini Tanzania. Wagonjwa  waliotibiwa kwa 
kawaida walikuwa na matatizo makubwa ya tyuma za muda mrefu. Kuna 
sababu nyingi zinazosababisha wagonjwa wengi kuchelewa kutibiwa. 
Sababu hizo ni pamoja na zile za kijamii–uchumi, na mfumo wa utoaji wa 
huduma za afya katika Tanzania. 
Ili kupanga utumishi na elimu na mafunzo kwa wataalamu wa upasuaji 
unaohusiana na kinywa, mataya na uso, ilionekana kwamba ni lazima 
kupata picha fulani ya ukubwa wa matatizo hayo. Kwa hiyo uchunguzi wa 
hali iliyopita na wa matazamio ya ile ijayo ya tyuma zinazohusiana na 
meno ulifikiriwa kuwa ni wa lazima. 
Kuna tatizo kubwa kuhusiana na “ubora wa maisha” ya wagonjwa ambao 
walifanyiwa upasuaji wa baadhi ya sehemu za taya la chini kutokana na 
tyuma ambazo sio sarakani lakini zenye uwezo wa kushambulia. Hadi 
kufikia mwaka 1999 hapakuwepo na jitihada zozote zilizofanyika za 
kuwafanyia uundaji upya wa taya wagonjwa hawa. Kwa hiyo, wagonjwa 
hawa, mara nyingi wamekuwa wakilemaa. Hivyo basi ilionekana haja ya 
kulipima na kulielewa tatizo hili pia. 
Mwaka 1999 kulianzishwa mbinu mpya ya kuwafanyia uundaji upya wa 
taya kundi teule la wagonjwa kwa upandikizaji maalumu wa mifupa 
kutoka sehemu nyingine ya mwili wa mgonjwa. Pia, lengo la utafiti huu 
lilikuwa ni kutathmini matokeo ya tiba hii pamoja na kupima kiwango cha 
kuridhika kwa wagonjwa kwa kutumia dodoso la “ubora wa maisha”. 
Kutokana na mambo yaliyotajwa hapo juu, maswali ya utafiti yafuatayo 
yaliundwa: 
• Wastani wa tyuma zinazohusiana na meno miongoni mwa 
Watanzania ni upi ikilinganishwa na aina nyingine za tyuma 
kwenye eneo la mdomo na uso? 
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 • Kuna msambao na utokeaji kiasi gani wa tyuma zinazohusiana na 
meno; na ni dalili gani anazojisikia mgonjwa au zinazoonekana na 
za kipatholojia zinazohusiana na tyuma hizi? 
• Ni kiwango gani cha utokeaji wa miksoma inayohusiana na 
maeneo ya meno; na kuna dalili zipi zinazoonekana au za 
kiradiografia na kipatholojia? 
• Kuna kiwango gani cha “ubora wa maisha” wa wagonjwa ambao 
walipata  upasuaji wa kuondoa tishu kutokana na tyuma 
zinazohusiana na meno bila kufanyiwa uundaji upya wa taya? 
• Je, inawezekana kuondoa ugonjwa na kufanya uundaji upya wa 
taya katika operesheni moja kwa wagonjwa ambao wanafanyiwa 
upasuaji wa kuondoa tishu kutokana na tyuma zinazohusiana na 
meno kwa kutumia mbinu rahisi? 
 
Sura ya 2. Lengo kubwa katika sura hii lilikuwa ni kupitia na kunukuu 
taarifa za kumbukumbu  za wagonjwa wenye tyuma zinazohusiana na 
meno katika kipindi cha zaidi ya miaka 15 nchini Tanzania. Kulifanyika 
mapitio ya ripoti za uchunguzi wa histolojia, mtawanyiko, sehemu ilipo 
tyuma mwilini, umri na jinsia nchini Tanzania kutoka mwaka 1982 mpaka 
1997. Kumbukumbu za wagonjwa waliokwenda kwenye vituo vinne vya 
rufaa nchini Tanzania na ambao historia ya uchunguzi wa kitaalamu 
ulithibitisha kuwa walikuwa na tyuma ya kinywa au hali ya uvimbe 
unaohusiana na meno zilifanyiwa uchunguzi. 
Kiwango cha tyuma zinazohusiana na meno kilikuwa asilimia 12.2 ya 
tyuma zote za kinywa na hali nyingine za uvimbe wa aina hiyo. Kiwango 
kikubwa cha tyuma zinazohusiana na meno (asilimia 55.3) zilipatikana 
miongoni mwa wagonjwa wenye umri chini ya miaka 30, na kwa ujumla 
waliathirika zaidi katika taya la chini kuliko taya la juu. 
Matokeo ya utafiti yalionyesha kuwa ameloblastoma ipo kwa kiwango 
kikubwa cha tyuma zinazohusiana na meno (asilimia 73.7) ikifuatiwa na 
miksoma (asilimia 10.3). Aidha, mtawanyiko wa ameloblastoma kwenye 
vipengele vya mahali ilipo tyuma, jinsia, na historia yake haukutofautiana 
na tafiti zingine zilizofanyika Afrika. Zaidi ya asilimia 50 ya wagonjwa wa 
ameloblastoma walichelewa kwenda kupata tiba hospitalini; mara nyingi 
hujitokeza baada ya miaka mitatu au zaidi. 
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 Sura ya 3 inahusu utafiti ambao ulilenga katika kuchunguza epidemiolojia 
na dalili mgonjwa anazozipata au zinazoonekana na za kipatholojia za 
tyuma zinazohusiana na meno, nchini Tanzania. Utafiti wa hali ya tyuma 
zinazohusiana na meno ulifanywa kwa zaidi ya miaka minne kati ya  
mwaka 1999 na mwaka 2003. Wagonjwa wote wenye tyuma 
zinazohusiana na  meno ambao walipata rufaa kutoka katika kliniki zote 
za matibabu ya meno na vituo vyote vya afya nchini kote kwenda katika 
vituo vinne vya rufaa walihusishwa katika utafiti. Hatimaye wagonjwa hao 
walipewa rufaa kwenda katika idara ya upasuaji wa kinywa, mataya na 
uso ya Chuo Kikuu Kisihiriki cha Sayansi ya Afya Muhimbili, Dar es 
Salaam, ambapo data zinazohusu umri, jinsia,  matokeo ya uchunguzi wa 
kihistolojia na kipatholojia ziliwekwa katika kumbukumbu. 
Sampuli za kihistolojia na kipatholojia zilishughulikiwa na kuchunguzwa 
kwa kina na Idara ya Tiba ya Chuo Kikuu Kishiriki cha Sayansi ya Afya, 
Muhimbili nchini Tanzania, na kufanyiwa mapitio na Idara ya Tiba ya 
Kinywa ya Free University Academic Hospital, mjini Amsterdam, nchini 
Uholanzi. Matokeo yalionyesha kwamba ameloblastoma iliongoza kwa 
kuwa na mdafao mkubwa (asilimia 80.1) na kiwango cha utokeaji ni 0.68 
kwa watu milioni moja ikifuatiwa na miksoma (asilimia 7.0) ambayo 
kiwango cha utokeaji ni 0.07 kwa watu milioni moja. Uchunguzi wa 
ufuatiliaji uliofanyika kwa wagonjwa kipindi cha kati ya miezi sita na miaka 
minne uligundua kwamba katika wagonjwa wawili ameloblastoma ilikuwa 
imerudia kutokea baada ya kutibiwa. Kwa ujumla wagonjwa wengi 
walichelewa kujitokeza kupata tiba, wengi wao walijitokeza hasa wakati 
ambapo walijihisi kuwa wana tatizo la kushindwa kutumia viungo husika 
au kupungukiwa uwezo wa kufanya shughuli zao za kila siku. 
 
Sura ya 4. Katika  sura hii umewasilishwa utafiti kuhusu miksoma 
inayohusiana na meno, aina ya tyuma ambayo hujitokeza katika taya na 
ni nadra; na imebainishwa kuwa inachukua nafasi ya pili ya aina za tyuma 
zinazohusiana na  meno katika nchi mbalimbali. Lengo la utafiti lilikuwa 
kubainisha/kuelezea dalili za ugonjwa wa miksoma inayohusiana na 
meno katika Tanzania. Kwa hiyo utafiti wa kina juu ya hali ya siku 
zilizopita ulifanywa kwa zaidi ya kipindi cha miaka 16 (1982-1998) na 
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 utafiti wa kina juu ya matarajio ulifanywa katika kipindi cha miaka minne 
(1999-2002). 
Jumla ya wagonjwa 33 wenye matatizo ya miksoma inayohusiana na 
meno walipatikana kwa uwiano wa 1:1.83 wa mwanaume kwa 
mwanamke. Tyuma (uvimbe) nyingi zilijitokeza katika taya la chini 
ukilinganisha na taya la juu. Maumivu, mishipa kupoteza fahamu, utungaji 
wa vidonda, uvamizi wa tishu na kulegea/kutikisika kwa meno ni 
mojawapo ya dalili ambazo zilionekana kwa wagonjwa ingawa wengi wao 
hawakuwa na dalili zozote za ugonjwa. 
 
Katika sura ya 5, lengo lilikuwa kutathmini matumizi ya kinywa na 
matokeo ya sura pamoja na hisia binafsi za wagonjwa wa Kitanzania 
ambao walifanyiwa upasuaji kuondoa sehemu tu ya taya la chini au 
kuondoa taya lote la chini kutokana na ameloblastoma bila ya taya 
kuundwa upya. Taarifa hizo zilipatikana kwa kutumia hokaji (dodoso) 
kuhusu ubora wa maisha. Wagonjwa ambao walikuwa na ameloblastoma 
ya taya la chini na ambao walitibiwa katika kipindi kati ya mwaka 2000 na 
2002, walishiriki katika utafiti. Wagonjwa tisa walifanyiwa upasuaji wa 
kuondoa taya la chini (total mandibulectomy) na wagonjwa kumi na sita 
walifanyiwa upasuaji wa kuondoa baadhi ya sehemu za taya la chini 
(segmental mandibulectomy). Baada ya kipindi kisichopungua mwaka 
mmoja wagonjwa walihojiwa. Ilibainishwa kuwa wagonjwa watano tu 
walikuwa wanalalamika kuwa na maumivu madogo madogo. Matatizo 
yaliyojitokeza baada ya upasuaji kwa kiasi kikubwa yalihusishwa na ulaji 
wa vyakula vigumu na watu wengine kutoridhishwa na muonekano wa 
sura zao na kuongea. 
Wagonjwa wote waliofanyiwa upasuaji mkubwa wa taya la chini walikuwa 
na matatizo madogo katika ulaji wa vyakula vigumu; na pia hawakuridhika 
na muonekano wa sura zao. 
Katika kundi la wagonjwa waliofanyiwa upasuaji wa kuondoa sehemu tu 
ya taya la chini, wagonjwa 12 walikuwa na matatizo ya wastani, na 
wagonjwa 2 walikuwa na matatizo makubwa katika ulaji wa vyakula 
vigumu. 
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 Katika sura ya 6 kuna maelezo ya matokeo ya kikundi cha wagonjwa 
kumi na moja ambao walifanyiwa uundaji upya wa taya la chini kwa 
kutumia mfupa kutoka sehemu nyingine mwilini mwao na uwekaji wa 
sehemu ya mfupa huo uliopasuliwa kuwa sehemu ndogondogo, 
kuchanganywa na PRP pamoja na kushikiza pleti iliyochongwa kwa ajili 
ya taya (SMART®, Martin Company, Ujerumani). 
Kutokana na utafiti huu tunajifunza kwamba kwa hakika uundaji upya wa 
taya baada ya kuondoa sehemu yenye ugonjwa  katika operesheni moja 
unawezekana kabisa kwa kutumia njia hii rahisi. Matokeo ya hojaji 
kuhusu ubora wa maisha kwa wagonjwa waliofanikiwa kutibiwa ipasavyo 
yalithibitisha mafanikio ya tiba hiyo. Namna ya uwekaji wa pleti 
iliyochongwa kushikilia meno ni murua, ili mradi tu ihusishe sehemu yote 
iliyokatwa kutoka upande mmoja hadi wa pili. 
Mfumo huu wa tiba unaweza kuhitaji kuboreshwa zaidi katika siku za 
baadaye kwa kutumia njia za uhandisi wa hali ya juu wa mifupa; hata 
hivyo kanuni za msingi juu ya uwekaji na uundaji wa awali wa taya 
ulithibitishwa kuwa ni murua. 
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 Mahitimisho 
 
1. Sehemu tyuma inapotokea mwilini, jinsia, na mtawanyo wa 
kihistolojia wa ameloblastoma haukuwa tofauti sana na tafiti 
nyingine zilizofanywa katika sehemu nyingine za Afrika.   
2. Ingawa ameloblastoma ilikuwa na mdafao mkubwa zaidi kupita 
aina zote za tyuma utokeaji wake katika eneo hili uliohusisha watu 
weusi pekee haukuwa tofauti na ule wa nchi za Ulaya. Hii ni 
tofauti na mawazo yaliyozoeleka ya kuwa ameloblastoma hutokea 
zaidi kwa watu weusi ikilinganishwa na watu wenye asili ya Ulaya. 
3. Ili kuboresha matokeo ya tiba hitaji la ugunduzi na urufani wa 
mapema wa wagonjwa unaofanywa na watumishi wa afya na 
wataalamu wa tiba ya meno unatiliwa mkazo. 
4. Inapotokea kuwa na tyuma inayohusiana na meno kama vile 
ameloblastoma au miksoma upasuaji unaohusisha kuondoa 
sehemu iliyoathirika pamoja na sehemu ziada kidogo isiyo na 
ugonjwa ndiyo njia bora yenye matokeo mazuri. Hii inasaidia 
kupunguza idadi ya wagonjwa wanaopata marudio ya tyuma.  
5. Tyuma zinaporipotiwa hospitalini zikiwa ndogo huwa na matokeo 
yanayoonyesha hali nzuri zaidi ya ubora wa maisha baada ya 
matibabu. Programu za uelimishaji wa umma za kuepusha au 
kuzuia ucheleweshaji wa rufaa na matibabu ni njia nzuri zaidi ya 
kupunguza idadi ya wagonjwa ambao baada ya kupata tiba wana 
hali duni ya maisha. 
6. Inawezekana kufanya uundaji upya wa taya baada ya kuondoa 
sehemu yenye ugonjwa katika operesheni moja kwa kutumia 
mbinu ya upandikizaji wa sehemu ndogondogo za mfupa ambao 
unatoka kwa mgonjwa mwenyewe na ambao umechanganywa na 
PRP na umeimarishwa na pleti (kipande kidogo bapa cha chuma 
ambacho hutumika katika kuunganisha mifupa kwa operesheni). 
Ilionekana kuwa ni njia nzuri sana ya kuongeza ubora wa maisha 
kwenye kundi la wagonjwa waliochaguliwa kwa umakini. 
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 Matazamio 
 
Kutokana na matokeo ya uchunguzi huu, katika Tanzania kuna haja ya 
kuanzisha vituo vingi ambapo aina hizi za uvimbe zinaweza kutibiwa. 
Vituo hivyo havina budi kuwekwa kwenye maeneo muafaka ya kijiografia 
ili kuwawezesha watu kupata huduma kwa kiwango cha kutosha. Hii ina 
maana kuwa wataalamu wa upasuaji wa kinywa, mataya na uso 
wanahitajika zaidi ili kukabiliana na jukumu hilo. Hatua hii ingepunguza 
matatizo ambayo sasa yanawakabili wagonjwa wengi wanaolazimika 
kusafiri kutoka wilaya mbalimbali na kwenda kwenye kituo kimoja 
kilichopo. Ingeweka pia mazingira mazuri ya ufuatiliaji wa wagonjwa na 
kutoa matibabu ya ziada yanapohitajika. Kwa siku za usoni, idara za tiba 
ya meno za hospitali za rufaa zilizoko Tanzania (KCMC, Bugando, na 
Mbeya) ambazo zimewekwa kwa malengo maalum ya kuhudumia nchi 
nzima lazima ziboreshwe kwa kuongezewa vifaa vya tiba na viwe na 
wafanyakazi wa kutosha na wenye uwezo. Ni muhimu kuelewa kuwa 
kuna mambo mengine yanayohitaji kushughulikiwa na wataalamu wa 
upasuaji wa kinywa, mataya na uso kama vile maambukizo, majeraha na 
vidonda, athari za sarakani, dosari za kuzaliwa nazo, na matatizo 
mengine. 
Ni wazi kuna hitaji la kuwa na programu ya uelimishaji wa umma. Hitaji la 
programu kama hii lipo pia kaika eneo la mafunzo ya ziada na elimu 
endelevu kwa waganga wa tiba ya meno, madaktari wasaidizi wa tiba ya 
meno na madaktari wa tiba ya meno ambao wanafanya kazi katika wilaya 
na mikoa mbalimbali. Programu hizo zinaweza kufanyika kwa kozi za 
maelekezo zinazoendeshwa na wataalamu wa upasuaji wa kinywa,  
mataya na uso kwa lengo la kuongeza ufanisi wao  katika ugunduzi wa 
magonjwa. Maarifa hayo yatawawezesha kugundua uvimbe na kuchukua 
hatua sahihi, na pale inapolazimu kuwatuma wagonjwa kwenye hospitali 
za rufaa. Itawasaidia pia kupeleka ujumbe au elimu sahihi kwa umma. 
Uchunguzi wa ubora wa maisha unaonyesha kwa kiasi hali ya 
kutokuridhika miongoni mwa wagonjwa wanaotibiwa bila  kufanyiwa 
uundaji wa taya. Uundaji upya wa taya wa kuridhisha unawezekana kwa 
wagonjwa wengi  ikiwa ni pamoja na mbinu iliyofafanuliwa katika 
uchunguzi huu na mbinu nyingine zinazohusisha upasuaji  kwa 
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 kuunganisha sehemu za mwili ndogondogo kama mishipa ya fahamu na 
mishipa ya damu. Inawezekana labda hapo baadaye njia hii ya upasuaji 
wa kuunganisha sehemu ndogondogo za mwili ikawa inafanywa katika 
katika kituo kimoja kikubwa. Njia hizi hata hivyo hutumia muda mwingi na 
zina gharama kubwa. Hii inazifanya aina hizo zisifae kwa matumizi ya 
kawaida katika nchi kama vile Tanzania mahali ambapo fedha kidogo 
zinazotengwa kwa ajili ya huduma za afya zinatumika kwenye shughuli 
zinazopewa vipaumbele muhimu zaidi. 
Vilevile uboreshaji wa uundaji upya wa taya unaweza kuhusisha mbinu za 
uhandishi wa tishu wa hali ya juu. Hata hivyo ni muhimu mbinu hizo 
zizingatie uwezo wa ulipaji wa mgonjwa Mtanzania. 
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 Samenvatting 
 
In Hoofdstuk 1 wordt uitgelegd wat de redenen zijn voor deze retrospec-
tieve en prospectieve studie. Odontogene tumoren vormen een groot deel 
van de dagelijkse werklast van de kaakchirurgen in Dar es Salaam, Tan-
zania. De patiënten presenteren zich meestal met zeer grote tumoren met 
een zeer lange geschiedenis. Er zijn verschillende factoren die bijdragen 
tot het feit dat patiënten in Tanzania zich zeer laat melden voor behan-
deling. Het gaat om socio-economische factoren, maar ook factoren 
gerelateerd aan de structuur van de gezondheidszorg in Tanzania. 
Teneinde een planning te kunnen maken met betrekking tot het aantal 
benodigde kaakchirurgen, maar ook met betrekking tot hun opleiding is 
het nodig om een indruk te krijgen van de grootte van de werklast. Om 
deze reden werd een retrospectieve en prospectieve studie gestart om de 
aard en de kwantiteit van de problemen te kunnen inschatten. 
De ervaring heeft geleerd dat de kwaliteit van leven van de patiënten die 
een partiële mandibulectomie hebben ondergaan voor een goedaardige 
maar toch agressieve tumor, te wensen overlaat. Tot 1999 werden bij 
deze patiëntengroep geen reconstructies uitgevoerd in Dar es Salaam. 
Het leek daarom wenselijk om een studie te doen naar de “Quality of Life” 
van deze patiënten teneinde hun problemen goed in kaart te kunnen 
brengen.  
In 1999 werd een reconstructietechniek ingevoerd in Dar es Salaam 
waarbij gebruik werd gemaakt van een speciale bottransplantatietech-
niek. Deze techniek werd toegepast bij een selectieve groep patiënten, 
die daarvoor in aanmerking kwamen. Het was dan ook de bedoeling om 
deze groep patiënten te evalueren en vooral de resultaten van deze tech-
niek te beoordelen in het kader van “Quality of Life”.  
Als gevolg van de bovengenoemde beschouwingen werden de volgende 
onderzoeksvragen geformuleerd: 
• Wat is de relatieve frequentie van odontogene tumoren bij de in-
woners van Tanzania, vooral in relatie tot andere tumoren in het 
orofaciale gebied. 
• Wat is de prevalentie en incidentie van odontogene tumoren en 
wat zijn de klinische en pathologische karakteristieke symptomen. 
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 • Wat is de incidentie van het odontogene myxoom en wat zijn de 
typische klinische, radiologische en pathologische kenmerken van 
deze zeer zeldzame tumor. 
• Wat is de “Quality of Life” van patiënten die een partiële man-
dibulectomie hebben ondergaan in verband met een agressieve, 
odontogene tumor zonder dat een reconstructie is toegepast. 
• Is het mogelijk om bij dergelijke patiënten het botdefect primair te 
reconstrueren met een speciaal ontwikkelde reconstructietech-
niek, bedoeld om te kunnen toepassen in een selectieve groep 
patiënten in Tanzania. 
 
In Hoofdstuk 2 wordt gerapporteerd over een retrospectieve studie naar 
het voorkomen van odontogene tumoren in Tanzania. De periode besloeg 
15 jaar en liep van 1982 tot 1997. De gegevens van alle patiënten die 
zich hadden gemeld bij de vier grote verwijzingscentra in Tanzania en die 
tumoren of tumorachtige condities hadden in het mond- en kaakgebied 
werden betrokken bij het onderzoek. Het bleek dat het percentage odon-
togene tumoren 12.2 bedroeg van alle tumoren. De grote meerderheid 
van deze odontogene tumoren werden gezien bij patiënten beneden een 
leeftijd van 30 jaar en de onderkaak was veel meer aangedaan dan de 
bovenkaak. Het ameloblastoom bleek de meest voorkomende tumor te 
zijn (73.7%) gevolgd door het odontogene myxoom (10.3%). De locatie, 
leeftijd waarbij de symptomen optreden en de histologische verscheiden-
heid van het ameloblastoom bleken niet te verschillen van de gegevens 
van andere Afrikaanse auteurs. Meer dan 50% van de patiënten met 
ameloblastomen presenteerden zich met een gezwel dat tenminste drie 
jaar aanwezig was of zelfs meer.  
 
In Hoofdstuk 3 wordt een prospectieve studie gepresenteerd uitgevoerd 
over een periode van 4 jaar tussen 1999 en 2003. De bedoeling was om 
epidemiologische, klinische en pathologische gegevens te verkrijgen van 
verschillende odontogene tumoren in Tanzania. Hiertoe werden alle 
patiënten met odontogene tumoren, die werden verwezen via tand-
heelkundige klinieken en andere gezondheidscentra in het land naar de 4 
regionale verwijzingscentra, betrokken. Uiteindelijk werden ze allen ver-
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 wezen naar het enige centrum in Tanzania waar mond- en kaakchirurgen 
werkzaam zijn. Voorafgaande aan het onderzoek werden alle potentiële 
medewerkers aan dit onderzoek in de diverse districten en regio’s be-
zocht door de onderzoeker en werd hun gewezen op het belang van hun 
medewerking aan dit onderzoek. Dit werd gedurende het onderzoek nog 
verschillende keren herhaald.  
De epidemiologische gegevens en de resultaten van het klinisch en het 
histologisch onderzoek werden vastgelegd. Het histologisch onderzoek 
werd uitgevoerd in Muhimbili, University College en vervolgens werden 
de preparaten nog gereviseerd op de afdeling orale pathologie van het 
Vrije Universiteit te Amsterdam. Hieruit bleek dat het ameloblastoom de 
hoogste relatieve frequentie toonde (80.1%). De “incidence rate” was 
echter 0.68 per miljoen. Dit is niet verschillend van de uitkomsten van on-
derzoek onder de Europese bevolking. Het odontogene myxoom heeft 
een relatieve frequentie van 7% met een “incidence rate” van 0.07 per 
miljoen. Dit bevestigt het zeldzame karakter van deze tumor. Alle 
patiënten met ameloblastomen werden gevolgd met al.s resultaat dat er 
twee patiënten met recidieven werden gediagnostiseerd. Dit is enigszins 
een vertekend beeld omdat ameloblastomen en odontogene myxomen de 
neiging hebben om nog na zeer vele jaren te kunnen recidiveren.  
In het al.gemeen bleek dat de patiënten zich pas meldden als de tumor 
een flinke omvang had aangenomen en wanneer zij reeds een aanzienlijk 
ongemak ervoeren.  
 
In Hoofdstuk 4 worden de odontogene myxomen behandeld. Het gaat 
om een zeer zeldzame tumor die uitsluitend in de kaak voorkomt maar 
die toch in de meeste ontwikkelingslanden als op een na meest frequent 
voorkomende tumor wordt beschouwd. Het het doel van deze studie was 
om de klinische en röntgenologische karakteristieken te beschrijven van 
een relatief grote groep odontogene myxomen in Tanzania. Het materiaal 
werd gedestilleerd uit een retrospectieve studie (1982-1998) en een 
prospectieve studie (1990-2002). Er werden in totaal 33 gevallen gevon-
den verdeeld over mannen en vrouwen in een verhouding van 1:1,83. De 
meeste tumoren waren gelocaliseerd in de mandibula en presenteerden 
zich vooral als multiloculaire afwijkingen. Pijn, dysaesthesie en mobiliteit 
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 van gebitselementen waren de kenmerken bij patiënten die zich presen-
teerden met symptomen, doch de meesten hadden nauwelijks klachten, 
behalve zwelling. Deze studie betreft de grootste serie gepresenteerd in 
de literatuur.  
 
In Hoofdstuk 5 worden de functionele en esthetische resultaten gepre-
senteerd van een groep patiënten die een partiële of een totale man-
dibulectomie hebben ondergaan in verband met een ameloblastoom en 
waarbij geen reconstructie plaats vond. Er werd gebruik gemaakt van een 
“Quality of Life” enquêteformulier, waarbij de bevindingen en de tevre-
denheid van de patiënt werden geregistreerd. Patiënten behandeld in de 
periode 2000 – 2002 participeerden in de studie. Er waren 9 patiënten bij 
wie een totale mandibulectomie werd verricht en 16 waarbij een partiële 
mandibulectomie werd verricht. Bij 27 patiënten werd na een jaar de en-
quête ingevuld. Vijf patiënten klaagden over milde pijn postoperatief, 
maar de meeste problemen werden ondervonden met het eten van hard 
tot stevig voedsel, esthetiek en spraak. Deze problemen traden vooral op 
bij patiënten bij wie een totale mandibulectomie was gebeurd. Bij de 
groep van de partiële mandibulectomiën waren deze problemen iets 
minder op de voorgrond tredend.  
 
Hoofdstuk 6 geeft de resultaten weer van een selecte groep patiënten bij 
wie een primaire reconstructie werd uitgevoerd na de ablatieve chirurgie. 
Hierbij werd gebruik gemaakt van autologe botpartikels vermengd met 
PRP terwijl de stabilisatie werd uitgevoerd met voorgebogen of rechte 2.3 
mm platen (SMART®, Martin Company, Germany). Bij drie van de 11 
patiënten slaagde de reconstructie niet vanwege een primaire wondde-
hiscentie in een geval en breken van de bestraalde corticale scafold in 
twee gevallen. Bij acht patiënten kon de ingreep echter als geslaagd 
worden gekwalificeerd. De postoperatieve “Quality of Life” uitkomsten 
bevestigen de klinische indruk. De methode van fixatie bleek adequaat te 
zijn, mits de platen het hele defect overspanden. Het lijkt erop dat dit 
model mogelijk nog verdere verbeteringen dient te ondergaan, maar het 
principe van de fixatie en de primaire reconstructie bleek practisch uit-
voerbaar.  
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 Conclusies 
 
1. Geslacht, locatie en de histologische verdeling van ameloblasto-
men in de onderhavige studie verschilde niet van die van andere 
Afrikaanse studies. 
2. Ondanks de hoge frequentie van de ameloblastomen in dit onder-
zoek, blijkt de “incidence rate” niet te verschillen van die gemeld in 
Europese studies. Dit is tegengesteld aan de opvatting, die door 
verschillende auteurs in de literatuur is gesuggereerd, namelijk dat 
ameloblastomen frequenter voorkomen bij zwarte mensen.  
3. Teneinde betere resultaten te boeken bij de behandeling van 
odontogene tumoren is het belangrijk om ze in een vroeg stadium 
te kunnen behandelen. Hiervoor is vroegtijdige diagnostiek en 
verwijzing noodzakelijk. 
4. In geval van benigne, maar agressieve odontogene tumoren zoals 
het odontogene myxoom en het ameloblastoom, is radicale chi-
rurgie noodzakelijk met een marge van tenminste 1 cm in gezond 
bot. 
5. De patiënten met relatief kleine tumoren scoren beter in een 
“Quality of Life” enquête. Om die reden is een goede voor-
lichtingscampagne waarschijnlijk de meest effectieve methode om 
het aantal patiënten, die na behandeling een slechte “Quality of 
Life” hebben, te verminderen.  
6. Primaire reconstructie gebruikmakend van autologe botpartikels 
vermengd met PRP en stabilisatie met behulp van voorgebogen 
platen is mogelijk. In dit beperkte onderzoek bleek dat er aan-
zienlijke verbetering van de “Quality of Life” kon worden bereikt. 
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 Toekomstperspectieven 
 
Uit de uitkomsten van deze studie kan worden geleerd dat er een 
noodzaak bestaat voor meer centra in Tanzania waar dit type tumor kan 
worden behandeld. Die centra zouden zodanig moeten zijn gelokaliseerd 
dat de hele bevolking adequaat kan worden bediend. Dat impliceert dat er 
meer mond- en kaakchirurgen noodzakelijk zijn. Deze maatregelen kun-
nen een belangrijke verbetering teweeg brengen van de problemen van 
de meeste patiënten, die over grote afstanden moeten reizen teneinde 
het enige centrum in Tanzania te bereiken, dat gelokaliseerd is in Dar es 
Salaam. Het zou ook een verbetering betekenen voor de noodzakelijke 
follow-up en de soms noodzakelijke additionele behandeling. De tand-
heelkundige afdeling van de bestaande grote regionale ziekenhuizen in 
Tanzania (KCMC, Bugando and Mbeya) zijn strategisch gelokaliseerd, 
zodanig dat ze het hele land kunnen bedienen. Door deze centra te be-
mannen met getrainde mond- kaakchirurgen, is de gezondheidszorg ten 
zeerste gediend. Men moet hierbij niet uit het oog verliezen dat mond- 
kaakchirurgen ook nog te maken hebben met grote aantallen patiënten 
met infecties, trauma’s, kwaadaardige gezwellen en congenitale afwijkin-
gen. 
 
Er is een duidelijke behoefte aan voorlichtingscampagnes onder de be-
volking maar ook is er behoefte aan additionele training en “continuing 
education” van “dental therapists”, “assistant dental officers” en tand-
artsen die in de districten en de regio’s werken. Dit kan worden bereikt 
door practische cursussen gegeven door mond- kaakchirurgen. Deze 
cursussen moeten gericht zijn op het vergroten van de klinische en diag-
nostische competentie. Deze kennis zou hen in staat stellen om tumoren 
eerder te diagnosticeren en de juiste maatregelen te nemen en zo nodig 
de patiënten te verwijzen naar een centrum. Dit zou ook helpen om het 
publiek beter te kunnen voorlichten. 
 
De “Quality of Life” studie geeft aan dat er een aanzienlijke ontevreden-
heid heerst onder de patiënten die werden behandeld zonder adequate 
reconstructie. Reconstructie lijkt mogelijk te zijn in vele gevallen met de 
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 voorgestelde techniek en zou in sommige gevallen ook kunnen worden 
uitgeoefend met een bottransplantatie gebaseerd op een microchirurgi-
sche techniek. Het is wellicht mogelijk om in de toekomst dit soort ge-
compliceerde microchirurgische reconstructies in één centrum te concen-
treren. Langdurige en dure reconstructies zijn in Tanzania echter niet ge-
schikt voor routine gebruik in verband met de beperkte fondsen. De hui-
dige reconstructietechniek zal wellicht kunnen profiteren van de vorderin-
gen die gemaakt worden op het gebied van “tissue engineering”. Er zal 
echter altijd een financiële afweging moeten worden gemaakt omdat het 
voor de Tanzaniaanse patiënt financieel bereikbaar moet kunnen zijn. 
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Nijmegen, May 12th 2005 
Statements 
 
1. In Tanzania odontogenic tumours are more frequently seen than 
oral cancer.  
 
2. The incidence of ameloblastoma among Blacks is not different 
from Caucasians. 
 
3. Odontogenic myxoma is a rare tumour but presents with similar 
signs and symptoms as ameloblastoma except that pain and 
dysaesthesia is more prominent. 
 
4. Late reporting to hospital is a common feature among patients 
suffering from odontogenic tumours in Tanzania.  
 
5. If patients undergo a (partial) mandibulectomy without 
reconstruction their quality of life (QOL) is generally poor. 
 
6. The level of incapacitation, following treatment for benign 
odontogenic tumours without reconstruction, is related to the size 
of the tumour and extent of the surgery.  
 
7. Primary reconstruction after resection of benign aggressive 
tumours appears to be possible using 2.3mm plates and 
condensed particulate cortico-cancellous bone grafts and platelet 
rich plasma.  
 
8. Autogenous platelet rich plasma, as a source of growth factors, 
can be easily prepared even in a developing country. 
 
9. The quality of life of patients, treated by ablative surgery for the 
treatment of benign odontogenic tumours, can be improved by 
reconstruction.  
 
10. The health care structure in Tanzania lends itself for prospective 
studies, provided intensive interaction exists between the main 
researcher and health care workers at all levels. 
 
11. Cooperation between developed countries and developing coun-
tries, if well pursued, can benefit patients who would otherwise 
lead miserable lives throughout.  
 
